AceView offers a comprehensive annotation of human, mouse and nematode genes
reconstructed by co-alignment and clustering of all publicly available
mRNAs and ESTs on the genome sequence. Our goals are to offer a reliable
up-to-date resource on the genes, their functions, alternative variants,
expression, regulation and interactions, in the hope to stimulate
further validating experiments at the bench
This site normally requires a frame enabled viewer,
However, click here to access our full description of gene PSMA1andCOPB1.
, go to our main page or see our latest news
Homo sapiens complex locus PSMA1andCOPB1, encoding coatomer protein complex, subunit beta 1 and proteasome (prosome, macropain) subunit, alpha type, 1.
TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Compact gene diagram
Alternative mRNAs are shown aligned from 5' to 3' on a virtual genome where introns have been shrunk to a minimal length. Exon size is proportional to length, intron height reflects the number of cDNAs supporting each intron. Introns of the same color are identical, of different colors are different. 'Good proteins' are pink, partial or not-good proteins are yellow, uORFs are green. 5' cap or3' poly A flags show completeness of the transcript.
Read more...
Mouse over the ending of each transcript gives tissues from which the supporting cDNAs were extracted. Details on tissue of origin for each intron and exon is available from the
intron and exons table.
Click on any transcript to open the specific mRNA page, to see the exact cDNA clone support and eventual SNPs and to get details on tissues, sequences, mRNA and protein annotations. Proteins supported by a single continuous cDNA sequence lead to underlining the name/ending of the variant. Names not underlined result from cDNA concatenation in the coding region and should be experimentally checked.
Introns are depicted by broken lines; the height of the top of each intron reflects the relative number of clones supporting this intron.
]^[ A pink broken line denotes an intron with standard boundaries (gt-ag or gc-ag) that is exactly supported (i.e. a cDNA sequence exactly matches the genome over 16 bp, 8 on both sides of the intron).
] ^ ] A blue broken line denotes non-standard introns, exactly supported, but with non-standard at-ac or any other boundaries.
]-[ Pink and
] - ] blue straight lines represent 'fuzzy' introns of the standard and non-standard types respectively, those introns do not follow the 16 bp rule. Black straight lines ]-[denote gaps in the alignments.
Exons: Wide filled pink areas represent putative protein coding regions, narrow empty pink boxes represent the 5'UTR (on the left) and 3' UTR (on the right). Flags identify validated endings: cap site on the 5' side, polyadenylation site on the 3' side. Filled flags correspond to frequent events while empty flags have lesser supporting cDNAs (yet all are validated); at the 3' side, black flags are associated to the main AATAAA signal,
blue flags to any single letter variant of the main . More explanations are given in the
gene help file
Expression and GenBank cDNA support
Tissues where expression was observed (from 832 cDNA clones)
Origin of the cDNAs, as reported in GenBank/dbEST (tissue, stage, pathological or normal) shows that the gene is expressed in brain (seen 48 times), testis (43), prostate (41), lung (32), thymus (31), trachea (27), liver (25), uterus (25), eye (23), placenta (20), stomach (20), placenta cot 25-normalized (16), cerebellum (15), hippocampus (15), pancreas (14), breast carcinoma (12), chondrosarcoma (12), embryonic stem cell, retinoic acid andmitogen-treated hes cell line H7 (12), kidney (11), leiomyosarcoma (11), colon (10), neuroblastoma (10), skin (10), tongue, tumor tissue (8), amygdala (7), embryonic stem cells, cell lines H1, H7, andh9 (7), lymph (7), purified pancreatic islet (7), bone (6), cell lines (6), embryonic stem cells, dmso-treated H9 cellline (6), embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells (6), fetal eye (6), large cell carcinoma (6), liver and spleen (6), lymphoma, cell line (6), melanotic melanoma (6), ovary (6), pooled colon, kidney, stomach (6), pooled pancreas and spleen (6), primary lung epithelial cells (6), small intestine (6), t-lymphocytes (6), thalamus (6), alzheimer cortex (5), ascites (5), embryonal carcinoma, cell line (5), myeloma (5), skeletal muscle (5), subthalamic nucleus (5), synovial membrane tissue from rheumatioidarthritis (5), bone marrow (4), cervix (4), embryonic stem (4), fetal eyes (4), human chondrosarcoma cell line (4), left pubic bone (4), neuroblastoma cells (4), adenocarcinoma (3), adenocarcinoma, cell line (3), blastocyst (3), blood (3), bone marrow, acute myelogenous leukemia (3), cell line (3), cervical carcinoma cell line (3), duodenal adenocarcinoma, cell line (3), human embryonic stem cells (3), human embryonic stem cells differentiated toan early endodermal cell type (3), insulinoma (3), islets of langerhans (3), lymph node (3), metastatic chondrosarcoma (3), neuroblastoma cot 10-normalized (3), pluripotent cell line derived fromblastocyst inner cell mass (3), retinoblastoma (3), spleen (3), whole embryo, mainly head (3), adipose (2), adrenal gland (2), aorta (2), bladder (2), carcinoma, cell line (2), caudate nucleus (2), cochlea (2), colon, tumor tissue (2), cord blood (2), dorsal root ganglia (2), ear (2), embryonal kidney (2), enchondroma (2), esophageal, tumor tissue (2), germinal center B cell (2), glioblastoma (2), heart (2), hepatoblastoma (2), hypothalamus (2), left pelvis (2), lens (2), leukopheresis (2), melanocyte (2), mucoepidermoid carcinoma (2), nervous normal (2), pooled lung and spleen (2), retina (2), small cell carcinoma (2), subchondral bone (2), three pooled meningiomas (2), transitional cell papilloma, cell line (2), whole brain (2), 2 pooled wilms' tumors, one primary and onemetastatic to brain (once), adenocarcinoma cell line (once), adrenal cortex carcinoma, cell line (once), aveolar macrophage (once), B cells (ramos cell line) cot 25-normalized (once), beard hair (once), blood vessels - aorta, basilar and artery (once), bone marrow stroma (once), brain, primitive neuroectodermal (once), breast, tumor tissue (once), chondrosarcoma grade II (once), choriocarcinoma (once), cornea (once), coronary artery (once), endometrioid ovarian metastasis (once), epithelioid carcinoma (once), ewing's sarcoma (once), from acute myelogenous leukemia (once), glioblastoma (pooled) (once), head neck (once), hela cells cot 25-normalized (once), human lung epithelial cells (once), human placenta (once), human skeletal muscle (once), hypernephroma (once), hypernephroma, cell line (once), leukocyte (once), liver, tumor tissue (once), lung normal (once), lymphoid (once), mammary gland (once), medulla (once), melanotic melanoma, high MDR (cell line) (once), metastatic prostate bone lesion (once), moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors (once), multiple sclerosis lesions (once), muscle (once), myeloid cells, 18 pooled CML cases, bcr/ablrearrangement positive, includes both chronic phase andmyeloid blast crisis (once), normal pigmented retinal epithelium (once), normal prostate (once), ovary, adenocarcinoma (once), ovary, tumor tissue (once), pituitary (once), placenta, choriocarcinoma (once), placenta normal (once), pooled-glandular (once), poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors (once), primary lung cystic fibrosis epithelialcells (once), primitive neuroectoderm (once), rectum (once), rhabdomyosarcoma (once), rpe/choroid (once), stomach, tumor tissue (once), substantia nigra (once), teratocarcinoma, cell line (once), tongue (once), trabecular meshwork (once), tumor (once), tumor, 5 pooled (see description) (once), uterus, tumor tissue (once), well-differentiated endometrialadenocarcinoma, 7 pooled tumors (once), whole blood (once).
832 cDNA clones support the 42 variants of gene PSMA1andCOPB1
?
This table helps analyze the pattern of expression of the gene, the tissue, cell type or disease state specificity of the alternative variants and to select cDNA clones suitable for your experiments.
cDNA accession Links to the sequence |
Tissue
most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features |
Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
NM_016451.4 | | .a | 1 to 3490 | 1 to 3490 | exact | RefSeq, | | 3490/3490 (100 %) | 0 diff (100 %id) |
DB153832 | thymus | .a | 2 to 584 | 2 to 584 | | tiling clone, capped | | 583/583 (100 %) | 1 diff (99.9 %id) |
DA460776 | tongue, tumor tissue | .a | 8 to 576 | 2 to 570 | | capped | | 569/569 (100 %) | 1 diff (99.9 %id) |
DB164712 | thymus | .a | 8 to 586 | 2 to 580 | | capped | | 579/579 (100 %) | 1 diff (99.9 %id) |
DB238193 | trachea | .a | 12 to 588 | 2 to 578 | | capped | | 577/577 (100 %) | 1 diff (99.9 %id) |
DA496320 | brain | .a | 18 to 575 | 2 to 559 | | capped | | 558/558 (100 %) | 3 diff (99.5 %id) |
DA854680 | placenta | .a | 47 to 629 | 2 to 585 | | capped | | 584/584 (100 %) | 2 diff (99.7 %id) |
DB151412 | thymus | .a | 47 to 601 | 2 to 556 | | capped | | 555/555 (100 %) | 3 diff (99.5 %id) |
DA030275 | | .a | 49 to 620 | 2 to 575 | | capped | | 574/575 (99 %) | 4 diff (99.4 %id) |
DA111965 | cerebellum | .a | 49 to 623 | 2 to 577 | | capped | | 576/576 (100 %) | 2 diff (99.7 %id) |
DA216394 | brain | .a | 49 to 630 | 2 to 585 | | capped | | 584/584 (100 %) | 2 diff (99.7 %id) |
DA459802 | tongue, tumor tissue | .a | 49 to 606 | 2 to 560 | | capped | | 559/559 (100 %) | 2 diff (99.7 %id) |
DA469063 | | .a | 49 to 626 | 2 to 580 | | capped | | 579/580 (99 %) | 3 diff (99.5 %id) |
DA547528 | | .a | 49 to 619 | 2 to 574 | | capped | | 573/573 (100 %) | 4 diff (99.4 %id) |
DA653568 | | .a | 49 to 574 | 2 to 528 | | capped | | 527/527 (100 %) | 1 diff (99.9 %id) |
DA862238 | placenta | .a | 49 to 574 | 2 to 528 | | capped | | 527/527 (100 %) | 4 diff (99.3 %id) |
DB095119 | testis | .a | 49 to 647 | 2 to 601 | | capped | | 600/600 (100 %) | 2 diff (99.7 %id) |
DB213870 | trachea | .a | 49 to 595 | 2 to 549 | | capped | | 548/548 (100 %) | 2 diff (99.7 %id) |
DB232486 | trachea | .a | 49 to 638 | 2 to 592 | | capped | | 591/591 (100 %) | 3 diff (99.5 %id) |
DB226866 | trachea | .a | 50 to 617 | 2 to 569 | | capped | | 568/568 (100 %) | 0 diff (100 %id) |
BG390931 | embryonal carcinoma, cell line, testis | .a | 60 to 796 | 1 to 737 | | | | 737/999 (73 %) | 16 diff (98.4 %id) |
BQ049868 | lymph, lymphoma, cell line | .a | 63 to 1007 | 1 to 952 | | tiling clone, | | 952/1030 (92 %) | 22 diff (97.9 %id) |
NM_001144061.1 | | .b | 1 to 3429 | 1 to 3429 | exact | RefSeq, | | 3429/3429 (100 %) | 0 diff (100 %id) |
DB084458 | testis | .b | 15 to 565 | 2 to 552 | | tiling clone, capped | | 551/551 (100 %) | 1 diff (99.9 %id) |
DA725605 | | .b | 22 to 577 | 2 to 557 | | capped | | 556/556 (100 %) | 0 diff (100 %id) |
BP353588 | | .b | 32 to 613 | 1 to 582 | | | | 582/582 (100 %) | 0 diff (100 %id) |
DB070523 | testis | .b | 32 to 576 | 2 to 546 | | capped | | 545/545 (100 %) | 0 diff (100 %id) |
DB079371 | testis | .b | 35 to 594 | 2 to 561 | | capped | | 560/560 (100 %) | 0 diff (100 %id) |
DB087432 | testis | .b | 35 to 587 | 2 to 554 | | capped | | 553/553 (100 %) | 0 diff (100 %id) |
DA206134 | brain | .b | 38 to 623 | 2 to 587 | | capped | | 586/586 (100 %) | 0 diff (100 %id) |
DA191478 | amygdala | .b | 39 to 622 | 2 to 585 | | capped | | 584/584 (100 %) | 0 diff (100 %id) |
DA413070 | thalamus | .b | 39 to 579 | 2 to 542 | | capped | | 541/541 (100 %) | 0 diff (100 %id) |
DA714497 | | .b | 40 to 590 | 2 to 552 | | capped | | 551/551 (100 %) | 0 diff (100 %id) |
DB097259 | testis | .b | 40 to 628 | 2 to 590 | | capped | | 589/589 (100 %) | 0 diff (100 %id) |
DA694521 | | .b | 42 to 579 | 2 to 539 | | capped | | 538/538 (100 %) | 0 diff (100 %id) |
DA193317 | amygdala | .b | 44 to 631 | 2 to 589 | | capped | | 588/588 (100 %) | 0 diff (100 %id) |
DA096013 | cerebellum | .b | 45 to 609 | 2 to 566 | | capped | | 565/565 (100 %) | 0 diff (100 %id) |
DA725983 | | .b | 45 to 606 | 2 to 563 | | capped | | 562/562 (100 %) | 0 diff (100 %id) |
DB093375 | testis | .b | 45 to 576 | 2 to 533 | | capped | | 532/532 (100 %) | 0 diff (100 %id) |
DB128696 | thymus | .b | 45 to 610 | 2 to 567 | | capped | | 566/566 (100 %) | 0 diff (100 %id) |
DB156160 | thymus | .b | 45 to 638 | 2 to 595 | | capped | | 594/594 (100 %) | 0 diff (100 %id) |
DB224630 | trachea | .b | 45 to 614 | 2 to 571 | | capped | | 570/570 (100 %) | 0 diff (100 %id) |
DA239962 | brain | .b | 48 to 653 | 2 to 607 | | capped | | 606/606 (100 %) | 0 diff (100 %id) |
BQ439114 | embryonal carcinoma, cell line, testis | .b | 49 to 871 | 1 to 828 | | | | 828/828 (100 %) | 6 diff (99.3 %id) |
BQ930035 | leiomyosarcoma, uterus | .b | 49 to 947 | 1 to 903 | | | | 903/932 (96 %) | 17 diff (98.2 %id) |
DA585944 | lung | .b | 52 to 587 | 2 to 537 | | capped | | 536/536 (100 %) | 0 diff (100 %id) |
DA644606 | | .b | 52 to 632 | 2 to 582 | | capped | | 581/581 (100 %) | 0 diff (100 %id) |
DB215659 | trachea | .b | 52 to 603 | 2 to 553 | | capped | | 552/552 (100 %) | 0 diff (100 %id) |
DA034134 | | .b | 53 to 579 | 2 to 528 | | capped | | 527/527 (100 %) | 0 diff (100 %id) |
DA661657 | | .b | 53 to 601 | 2 to 550 | | capped | | 549/549 (100 %) | 0 diff (100 %id) |
DA720986 | | .b | 53 to 609 | 2 to 558 | | capped | | 557/557 (100 %) | 0 diff (100 %id) |
DA725008 | | .b | 53 to 616 | 2 to 565 | | capped | | 564/564 (100 %) | 0 diff (100 %id) |
DA754829 | | .b | 53 to 582 | 2 to 531 | | capped | | 530/530 (100 %) | 0 diff (100 %id) |
DA984040 | synovial membrane tissue from rheumatioidarthritis | .b | 53 to 615 | 2 to 564 | | capped | | 563/563 (100 %) | 0 diff (100 %id) |
DB061067 | testis | .b | 53 to 590 | 2 to 539 | | capped | | 538/538 (100 %) | 0 diff (100 %id) |
DB141768 | thymus | .b | 53 to 579 | 2 to 528 | | capped | | 527/527 (100 %) | 0 diff (100 %id) |
DB145541 | thymus | .b | 53 to 601 | 2 to 550 | | capped | | 549/549 (100 %) | 0 diff (100 %id) |
DB219819 | trachea | .b | 53 to 609 | 2 to 558 | | capped | | 557/557 (100 %) | 0 diff (100 %id) |
BM480138 | eye, retinoblastoma | .b | 67 to 1091 | 43 to 1072 | | tiling clone, | | 1030/1156 (89 %) | 24 diff (98.0 %id) |
AL136593 | amygdala | .b | 69 to 3379 | 1 to 3311 | exact | tiling clone, available from DKFZ, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 3311/3311 (100 %) | 1 diff (100.0 %id) |
DA521204 | brain | .b | 79 to 645 | 2 to 568 | | capped | | 567/567 (100 %) | 0 diff (100 %id) |
BM828494 | Ascites, stomach | .b | 85 to 739 | 1 to 655 | | | | 655/655 (100 %) | 0 diff (100 %id) |
DA647480 | | .b | 86 to 898 | 2 to 817 | | capped | | 814/816 (99 %) | 9 diff (98.9 %id) |
DA648623 | | .b | 86 to 620 | 2 to 536 | | capped | | 535/535 (100 %) | 0 diff (100 %id) |
DA653161 | | .b | 86 to 674 | 2 to 590 | | capped | | 589/589 (100 %) | 0 diff (100 %id) |
DA654219 | | .b | 86 to 678 | 2 to 594 | | capped | | 593/593 (100 %) | 0 diff (100 %id) |
DA658820 | | .b | 86 to 663 | 2 to 579 | | capped | | 578/578 (100 %) | 0 diff (100 %id) |
DA688128 | | .b | 86 to 618 | 2 to 534 | | capped | | 533/533 (100 %) | 0 diff (100 %id) |
DA709686 | | .b | 86 to 643 | 2 to 559 | | capped | | 558/558 (100 %) | 0 diff (100 %id) |
DA720016 | | .b | 86 to 649 | 2 to 565 | | capped | | 564/564 (100 %) | 0 diff (100 %id) |
DA722068 | | .b | 86 to 642 | 2 to 558 | | capped | | 557/557 (100 %) | 0 diff (100 %id) |
DA722100 | | .b | 86 to 642 | 2 to 558 | | capped | | 557/557 (100 %) | 0 diff (100 %id) |
DB158064 | thymus | .b | 86 to 666 | 2 to 582 | | capped | | 581/581 (100 %) | 0 diff (100 %id) |
DB161293 | thymus | .b | 86 to 660 | 2 to 576 | | capped | | 575/575 (100 %) | 0 diff (100 %id) |
DB215591 | trachea | .b | 86 to 624 | 2 to 540 | | capped | | 539/539 (100 %) | 0 diff (100 %id) |
DA437192 | tongue, tumor tissue | .b | 89 to 703 | 2 to 616 | | capped | | 615/615 (100 %) | 0 diff (100 %id) |
DA817930 | | .b | 94 to 651 | 2 to 559 | | capped | | 558/558 (100 %) | 0 diff (100 %id) |
CN362445 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .b | 97 to 842 | 1 to 746 | | | | 746/746 (100 %) | 0 diff (100 %id) |
AF084457 | | .b | 101 to 3379 | 1 to 3278 | D825E F847L I911S I915L G925V ... | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 3278/3278 (100 %) | 11 diff (99.7 %id) |
BP197285 | adrenal gland | .b | 111 to 693 | 1 to 583 | | | | 583/583 (100 %) | 0 diff (100 %id) |
DA723331 | | .b | 112 to 667 | 2 to 557 | | capped | | 556/556 (100 %) | 0 diff (100 %id) |
CN362439 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .b | 137 to 886 | 1 to 750 | | | | 750/751 (99 %) | 1 diff (99.9 %id) |
DA648477 | | .b | 207 to 759 | 2 to 554 | | capped | | 553/553 (100 %) | 0 diff (100 %id) |
DA519717 | brain | .b | 258 to 806 | 2 to 550 | | capped | | 549/549 (100 %) | 0 diff (100 %id) |
DA729718 | | .b | 293 to 834 | 2 to 543 | | capped | | 542/542 (100 %) | 0 diff (100 %id) |
BU190069 | leiomyosarcoma, uterus | .b | 406 to 1293 | 1 to 889 | | | | 889/890 (99 %) | 6 diff (99.4 %id) |
DB259981 | uterus | .b | 464 to 1049 | 2 to 587 | | capped | | 586/586 (100 %) | 0 diff (100 %id) |
AA019491 | eye, retina | .b | 491 to 666 | 1 to 176 | | | | 176/176 (100 %) | 1 diff (99.5 %id) |
DA757695 | | .b | 498 to 1041 | 2 to 545 | | capped | | 544/544 (100 %) | 0 diff (100 %id) |
CN362458 | embryonic stem cells, cell lines H1, H7, andH9 | .b | 514 to 1174 | 1 to 662 | | | | 662/662 (100 %) | 1 diff (99.9 %id) |
BP376522 | uterus | .b | 734 to 1314 | 1 to 581 | | | | 581/581 (100 %) | 0 diff (100 %id) |
DA467298 | cord Blood | .b | 743 to 1299 | 2 to 558 | | capped | | 557/557 (100 %) | 0 diff (100 %id) |
BP313681 | mammary gland | .b | 749 to 1330 | 1 to 582 | | | | 582/582 (100 %) | 0 diff (100 %id) |
DA449699 | tongue, tumor tissue | .b | 752 to 1311 | 2 to 561 | | capped | | 560/560 (100 %) | 0 diff (100 %id) |
DA141439 | alzheimer cortex | .b | 828 to 1399 | 2 to 573 | | capped | | 572/572 (100 %) | 0 diff (100 %id) |
DA889091 | | .b | 828 to 1374 | 2 to 548 | | capped | | 547/547 (100 %) | 0 diff (100 %id) |
DA386085 | thalamus | .b | 927 to 1492 | 2 to 567 | | capped | | 566/566 (100 %) | 0 diff (100 %id) |
BM832679 | stomach | .b | 939 to 1547 | 3 to 611 | | | | 609/611 (99 %) | 0 diff (100 %id) |
DA503490 | brain | .b | 960 to 1529 | 2 to 571 | | capped | | 570/570 (100 %) | 0 diff (100 %id) |
DA816895 | | .b | 964 to 1530 | 2 to 568 | | capped | | 567/567 (100 %) | 0 diff (100 %id) |
DA530906 | brain | .b | 979 to 1516 | 2 to 539 | | capped | | 538/538 (100 %) | 0 diff (100 %id) |
DA632476 | Kidney | .b | 982 to 1542 | 2 to 562 | | capped | | 561/561 (100 %) | 0 diff (100 %id) |
AK001203 | | .b | 993 to 2629 | 1 to 1637 | | available from FLJ, | | 1637/1637 (100 %) | 2 diff (99.9 %id) |
DA479629 | | .b | 995 to 1517 | 2 to 524 | | capped | | 523/523 (100 %) | 0 diff (100 %id) |
DA260150 | caudate nucleus | .b | 998 to 1569 | 2 to 573 | | capped | | 572/572 (100 %) | 0 diff (100 %id) |
DA785529 | brain | .b | 1108 to 1678 | 2 to 572 | | capped | | 571/571 (100 %) | 0 diff (100 %id) |
DA478841 | | .b | 1110 to 1669 | 2 to 561 | | capped | | 560/560 (100 %) | 0 diff (100 %id) |
DB034480 | testis | .b | 1111 to 1683 | 2 to 574 | | capped | | 573/573 (100 %) | 0 diff (100 %id) |
BU195107 | melanotic melanoma, skin | .b | 1129 to 1982 | 1 to 862 | | | | 862/877 (98 %) | 20 diff (97.8 %id) |
DA901419 | | .b | 1133 to 1657 | 2 to 526 | | capped | | 525/525 (100 %) | 0 diff (100 %id) |
CB118545 | Liver | .b | 1293 to 1955 | 1 to 663 | | | | 663/663 (100 %) | 0 diff (100 %id) |
BM722232 | eye, fetal eye | .b | 1330 to 1996 | 1 to 667 | | | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 667/667 (100 %) | 0 diff (100 %id) |
DA603197 | | .b | 1347 to 1931 | 2 to 586 | | capped | | 585/585 (100 %) | 0 diff (100 %id) |
BP351225 | | .b | 1354 to 1935 | 1 to 582 | | | | 582/582 (100 %) | 0 diff (100 %id) |
BM457913 | lymph, lymphoma, cell line | .b | 1364 to 2241 | 1 to 881 | | | | 881/881 (100 %) | 9 diff (99.0 %id) |
CR605573 | B cells (Ramos cell line) Cot 25-normalized | .b | 1365 to 3368 | 1 to 2004 | | | | 2004/2004 (100 %) | 0 diff (100 %id) |
DA344309 | substantia nigra | .b | 1368 to 1929 | 2 to 563 | | capped | | 562/562 (100 %) | 0 diff (100 %id) |
BM829544 | Ascites, stomach | .b | 1377 to 2044 | 1 to 668 | | | | 668/668 (100 %) | 0 diff (100 %id) |
CN362456 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 1435 to 2052 | 1 to 618 | | | | 618/618 (100 %) | 0 diff (100 %id) |
BP205597 | coronary artery | .b | 1550 to 2131 | 1 to 582 | | | | 582/582 (100 %) | 0 diff (100 %id) |
DA519375 | brain | .b | 1561 to 2106 | 2 to 547 | | capped | | 546/546 (100 %) | 0 diff (100 %id) |
DA519393 | brain | .b | 1561 to 2109 | 2 to 550 | | capped | | 549/549 (100 %) | 0 diff (100 %id) |
BP253816 | Kidney | .b | 1566 to 2147 | 1 to 582 | | | | 582/582 (100 %) | 0 diff (100 %id) |
BP329411 | rectum | .b | 1577 to 2157 | 1 to 581 | | | | 581/581 (100 %) | 0 diff (100 %id) |
BM454324 | lymph, lymphoma, cell line | .b | 1589 to 2464 | 1 to 883 | | | | 883/1061 (83 %) | 9 diff (99.2 %id) |
BJ994596 | hepatoblastoma | .b | 1709 to 2305 | 1 to 597 | | | | 597/597 (100 %) | 1 diff (99.9 %id) |
BM785334 | stomach | .b | 1715 to 2384 | 1 to 670 | | | | 670/670 (100 %) | 0 diff (100 %id) |
BP262364 | small intestine | .b | 1723 to 2305 | 1 to 583 | | | | 583/583 (100 %) | 0 diff (100 %id) |
BI793325 | Islets of Langerhans, Pancreas | .b | 1754 to 2328 | 1 to 575 | | | | 575/575 (100 %) | 0 diff (100 %id) |
CN362451 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 1771 to 2260 | 1 to 490 | | | | 490/490 (100 %) | 0 diff (100 %id) |
BU195282 | eye, retinoblastoma | .b | 1774 to 2649 | 1 to 889 | | | | 889/889 (100 %) | 23 diff (97.5 %id) |
BP252211 | Kidney | .b | 1780 to 2363 | 1 to 584 | | | | 584/584 (100 %) | 0 diff (100 %id) |
CN362434 | embryonic stem cells, DMSO-treated H9 cellline | .b | 1864 to 2299 | 1 to 436 | | | | 436/436 (100 %) | 0 diff (100 %id) |
BQ228595 | melanotic melanoma, skin | .b | 1923 to 2775 | 1 to 862 | | | | 862/864 (99 %) | 18 diff (98.0 %id) |
AW352438 | stomach | .b | 1930 to 2450 | 1 to 521 | | | | 521/521 (100 %) | 0 diff (100 %id) |
CB164812 | Liver | .b | 1968 to 2534 | 1 to 567 | | | | 567/567 (100 %) | 0 diff (100 %id) |
BQ929381 | leiomyosarcoma, uterus | .b | 1973 to 2831 | 5 to 862 | | | | 858/864 (99 %) | 4 diff (99.6 %id) |
DR762849 | embryonic stem | .b | 1977 to 2869 | 13 to 905 | | | | 893/905 (98 %) | 0 diff (100 %id) |
BM541482 | leiomyosarcoma, uterus | .b | 2014 to 3049 | 1 to 1047 | | | | 1047/1073 (97 %) | 31 diff (97.2 %id) |
BM722651 | eye, fetal eye | .b | 2014 to 2662 | 1 to 649 | | | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 649/649 (100 %) | 0 diff (100 %id) |
BM766520 | Ascites, stomach | .b | 2026 to 2477 | 1 to 452 | | | | 452/452 (100 %) | 0 diff (100 %id) |
BM767271 | Ascites, stomach | .b | 2026 to 2647 | 1 to 622 | | | | 622/622 (100 %) | 0 diff (100 %id) |
CX784094 | human embryonic stem cells | .b | 2028 to 2786 | 1 to 759 | | | | 759/759 (100 %) | 0 diff (100 %id) |
DA001725 | | .b | 2065 to 2616 | 2 to 553 | | capped | | 552/552 (100 %) | 0 diff (100 %id) |
BI760429 | pooled colon, kidney, stomach | .b | 2069 to 2664 | 1 to 596 | | | | 596/596 (100 %) | 0 diff (100 %id) |
BF970532 | adrenal cortex carcinoma, cell line, adrenal gland | .b | 2073 to 2873 | 1 to 802 | | | | 802/904 (88 %) | 18 diff (98.1 %id) |
BG120345 | adenocarcinoma, cell line, Liver | .b | 2119 to 2877 | 1 to 758 | | | | 758/758 (100 %) | 4 diff (99.5 %id) |
BX100364 | melanocyte | .b | 2123 to 2919 | 1 to 798 | | | | 798/798 (100 %) | 1 diff (99.9 %id) |
CB123287 | Liver | .b | 2170 to 2882 | 1 to 713 | | | | 713/713 (100 %) | 0 diff (100 %id) |
DA452867 | tongue, tumor tissue | .b | 2175 to 2756 | 2 to 583 | | capped | | 582/582 (100 %) | 0 diff (100 %id) |
X82103 | lymphoid | .b | 2197 to 3379 | 1 to 1183 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 1183/1183 (100 %) | 9 diff (99.3 %id) |
BP288865 | lung | .b | 2240 to 2820 | 1 to 581 | | | | 581/581 (100 %) | 0 diff (100 %id) |
AA447898 | | .b | 2269 to 2772 | 1 to 504 | | | | 504/504 (100 %) | 0 diff (100 %id) |
CB131652 | Liver | .b | 2282 to 2804 | 529 to 7 | | | Submitted on the opposite strand | 523/529 (98 %) | 0 diff (100 %id) |
CD558135 | testis | .b | 2291 to 3124 | 1 to 837 | | | | 837/837 (100 %) | 7 diff (99.2 %id) |
BM753160 | stomach | .b | 2398 to 2959 | 1 to 562 | | | | 562/562 (100 %) | 0 diff (100 %id) |
BM765733 | stomach | .b | 2398 to 3044 | 1 to 647 | | | | 647/647 (100 %) | 0 diff (100 %id) |
DA028604 | | .b | 2425 to 2991 | 2 to 568 | | capped | | 567/567 (100 %) | 0 diff (100 %id) |
CN362447 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 2476 to 2970 | 1 to 495 | | | | 495/495 (100 %) | 0 diff (100 %id) |
TI_149272286 | | .b | 2537 to 3379 | 928 to 99 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 830/984 (84 %) | 14 diff (98.6 %id) |
TI_149311095 | | .b | 2550 to 3379 | 901 to 84 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 818/981 (83 %) | 13 diff (98.7 %id) |
TI_149273747 | | .b | 2552 to 3419 | 950 to 88 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 863/864 (99 %) | 10 diff (98.9 %id) |
TI_159709850 | | .b | 2559 to 3379 | 921 to 99 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 823/975 (84 %) | 19 diff (98.1 %id) |
TI_154131119 | | .b | 2575 to 3379 | 891 to 91 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 801/983 (81 %) | 13 diff (98.7 %id) |
BM977306 | lung, Primary Lung Epithelial Cells | .b | 2585 to 3379 | 804 to 17 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 788/788 (100 %) | 8 diff (99.0 %id) |
TI_154125033 | | .b | 2601 to 3419 | 901 to 89 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 813/953 (85 %) | 11 diff (98.9 %id) |
TI_149295296 | | .b | 2610 to 3379 | 852 to 84 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 769/985 (78 %) | 2 diff (99.8 %id) |
BU620120 | Cell Line, Chondrosarcoma | .b | 2620 to 3379 | 771 to 17 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 755/756 (99 %) | 9 diff (98.9 %id) |
W95031 | liver and spleen | .b | 2632 to 3079 | 1 to 451 | | fully sequenced, | | 449/449 (100 %) | 2 diff (99.6 %id) |
TI_154059362 | | .b | 2646 to 3419 | 837 to 66 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 772/972 (79 %) | 8 diff (99.2 %id) |
CA419622 | Bone, Human Chondrosarcoma Cell Line | .b | 2646 to 3419 | 790 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 772/820 (94 %) | 8 diff (99.1 %id) |
BU618151 | Cell Line, Chondrosarcoma | .b | 2646 to 3379 | 746 to 17 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 730/739 (98 %) | 8 diff (99.0 %id) |
TI_149283213 | | .b | 2647 to 3379 | 809 to 78 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 732/819 (89 %) | 11 diff (98.7 %id) |
BQ009259 | Chondrosarcoma, Left Pubic Bone | .b | 2649 to 3419 | 789 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 771/771 (100 %) | 0 diff (100 %id) |
CA426979 | Bone, Subchondral Bone | .b | 2655 to 3379 | 742 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 724/730 (99 %) | 1 diff (99.9 %id) |
BU625049 | cell lines, Enchondroma | .b | 2658 to 3419 | 778 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 760/805 (94 %) | 4 diff (99.6 %id) |
CA414248 | Chondrosarcoma Grade II, Left Pelvis | .b | 2662 to 3379 | 736 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 718/718 (100 %) | 1 diff (99.9 %id) |
CA424550 | cell lines, Chondrosarcoma | .b | 2662 to 3377 | 734 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 716/716 (100 %) | 1 diff (99.9 %id) |
BU620947 | cell lines, Chondrosarcoma | .b | 2662 to 3419 | 776 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 758/758 (100 %) | 1 diff (99.9 %id) |
CA418024 | Bone, Human Chondrosarcoma Cell Line | .b | 2674 to 3379 | 721 to 17 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 705/705 (100 %) | 2 diff (99.8 %id) |
BQ007049 | Chondrosarcoma, Left Pelvis | .b | 2675 to 3419 | 763 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 745/745 (100 %) | 0 diff (100 %id) |
BE906954 | epithelioid carcinoma, Pancreas | .b | 2676 to 3284 | 1 to 609 | | | | 609/610 (99 %) | 1 diff (99.9 %id) |
BU622833 | cell lines, Enchondroma | .b | 2694 to 3419 | 745 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 727/735 (98 %) | 1 diff (99.9 %id) |
DB078416 | testis | .b | 2696 to 3275 | 2 to 581 | | capped | | 580/580 (100 %) | 0 diff (100 %id) |
BM985396 | lung | .b | 2706 to 3379 | 690 to 17 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 674/674 (100 %) | 0 diff (100 %id) |
TI_154020403 | | .b | 2713 to 3379 | 752 to 86 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 667/706 (94 %) | 0 diff (100 %id) |
TI_149290873 | | .b | 2722 to 3423 | 780 to 79 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 702/702 (100 %) | 2 diff (99.8 %id) |
BG571457 | placenta | .b | 2750 to 3415 | 1 to 667 | | | | 667/849 (78 %) | 7 diff (99.2 %id) |
BM679140 | eye, fetal eye | .b | 2762 to 3423 | 679 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 661/661 (100 %) | 7 diff (99.0 %id) |
BM968189 | lung, Primary Lung Epithelial Cells | .b | 2765 to 3419 | 673 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 655/655 (100 %) | 0 diff (100 %id) |
BM311300 | Pancreas, Purified pancreatic islet | .b | 2773 to 3382 | 610 to 1 | | | | 610/610 (100 %) | 1 diff (99.9 %id) |
CK821136 | Islets of Langerhans, Pancreas | .b | 2789 to 3379 | 591 to 1 | | | | 591/591 (100 %) | 0 diff (100 %id) |
CA438403 | lung, Metastatic Chondrosarcoma | .b | 2790 to 3379 | 606 to 17 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 590/590 (100 %) | 0 diff (100 %id) |
CB049590 | Prostate | .b | 2791 to 3419 | 652 to 24 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 629/629 (100 %) | 0 diff (100 %id) |
BI793018 | Islets of Langerhans, Pancreas | .b | 2797 to 3379 | 583 to 1 | | | | 583/583 (100 %) | 0 diff (100 %id) |
BU680105 | lung, Primary Lung Epithelial Cells | .b | 2800 to 3379 | 596 to 17 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 580/580 (100 %) | 0 diff (100 %id) |
TI_149308196 | | .b | 2803 to 3419 | 708 to 92 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 617/958 (64 %) | 0 diff (100 %id) |
TI_159722108 | | .b | 2803 to 3419 | 709 to 93 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 617/992 (62 %) | 0 diff (100 %id) |
BU687062 | lung, Primary Lung Epithelial Cells | .b | 2803 to 3419 | 635 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 617/628 (98 %) | 0 diff (100 %id) |
BU681922 | lung | .b | 2803 to 3423 | 639 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 621/628 (98 %) | 1 diff (99.9 %id) |
CA944469 | Human Lung Epithelial cells, lung | .b | 2803 to 3419 | 635 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 617/624 (98 %) | 0 diff (100 %id) |
BU616583 | Cell Line, Chondrosarcoma | .b | 2803 to 3423 | 640 to 19 | | tiling clone, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 622/629 (98 %) | 1 diff (99.9 %id) |
AW305092 | brain, three pooled meningiomas | .b | 2809 to 3419 | 611 to 1 | | | | 611/611 (100 %) | 0 diff (100 %id) |
AU309773 | neuroblastoma | .b | 2814 to 3379 | 600 to 35 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 566/566 (100 %) | 0 diff (100 %id) |
CN479974 | Chondrosarcoma, Left Pubic Bone | .b | 2823 to 3419 | 615 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 597/597 (100 %) | 0 diff (100 %id) |
BQ017750 | Chondrosarcoma, Left Pubic Bone | .b | 2834 to 3423 | 608 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 590/590 (100 %) | 0 diff (100 %id) |
AA809501 | germinal center B cell | .b | 2842 to 3379 | 548 to 11 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 538/538 (100 %) | 0 diff (100 %id) |
AI860851 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .b | 2842 to 3382 | 541 to 1 | | | | 541/541 (100 %) | 0 diff (100 %id) |
BU740088 | eye, fetal eye | .b | 2846 to 3419 | 592 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 574/574 (100 %) | 0 diff (100 %id) |
BJ994597 | hepatoblastoma | .b | 2879 to 3384 | 506 to 1 | | | | 506/506 (100 %) | 0 diff (100 %id) |
AW468574 | myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood | .b | 2881 to 3379 | 499 to 1 | | | | 499/499 (100 %) | 0 diff (100 %id) |
AA703192 | liver and spleen | .b | 2887 to 3379 | 493 to 1 | | | | 493/493 (100 %) | 0 diff (100 %id) |
AA554780 | colon, tumor | .b | 2890 to 3360 | 471 to 1 | | | | 471/471 (100 %) | 0 diff (100 %id) |
AI129763 | uterus | .b | 2890 to 3379 | 490 to 1 | | | | 490/490 (100 %) | 0 diff (100 %id) |
AW515386 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .b | 2908 to 3420 | 513 to 1 | | | | 513/513 (100 %) | 0 diff (100 %id) |
BF439861 | brain, glioblastoma (pooled) | .b | 2908 to 3420 | 513 to 1 | | | | 513/513 (100 %) | 0 diff (100 %id) |
CA419598 | Bone, Human Chondrosarcoma Cell Line | .b | 2934 to 3379 | 462 to 17 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 446/446 (100 %) | 0 diff (100 %id) |
AA701438 | liver and spleen | .b | 2938 to 3419 | 482 to 1 | | | | 482/482 (100 %) | 0 diff (100 %id) |
CN362462 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 2977 to 3417 | 1 to 441 | | | | 441/441 (100 %) | 0 diff (100 %id) |
AA448840 | | .b | 3014 to 3419 | 406 to 1 | | | | 406/406 (100 %) | 0 diff (100 %id) |
W93327 | liver and spleen | .b | 3018 to 3419 | 402 to 1 | | fully sequenced, | | 402/402 (100 %) | 0 diff (100 %id) |
AA019202 | eye, retina | .b | 3149 to 3420 | 272 to 1 | | | | 272/272 (100 %) | 0 diff (100 %id) |
NM_001144062.1 | | .c | 1 to 3368 | 1 to 3368 | exact | RefSeq, | | 3368/3368 (100 %) | 0 diff (100 %id) |
DB139571 | thymus | .c | 1 to 545 | 2 to 546 | | tiling clone, capped | | 545/545 (100 %) | 1 diff (99.9 %id) |
DA163007 | amygdala | .c | 2 to 580 | 2 to 580 | | capped | | 579/579 (100 %) | 5 diff (99.2 %id) |
DB221316 | trachea | .c | 2 to 553 | 2 to 553 | | capped | | 552/552 (100 %) | 1 diff (99.9 %id) |
DB233059 | trachea | .c | 2 to 586 | 2 to 586 | | capped | | 585/585 (100 %) | 1 diff (99.9 %id) |
DB078615 | testis | .c | 4 to 564 | 2 to 562 | | capped | | 561/561 (100 %) | 0 diff (100 %id) |
DB084832 | testis | .c | 4 to 559 | 2 to 557 | | capped | | 556/556 (100 %) | 2 diff (99.7 %id) |
DB075847 | testis | .c | 6 to 556 | 2 to 552 | | capped | | 551/551 (100 %) | 0 diff (100 %id) |
DB097974 | testis | .c | 6 to 595 | 2 to 591 | | capped | | 590/590 (100 %) | 3 diff (99.5 %id) |
DA749189 | | .c | 9 to 572 | 2 to 565 | | capped | | 564/566 (99 %) | 4 diff (99.3 %id) |
DB158960 | thymus | .c | 9 to 571 | 2 to 564 | | capped | | 563/564 (99 %) | 3 diff (99.5 %id) |
DB210490 | trachea | .c | 9 to 553 | 2 to 546 | | capped | | 545/545 (100 %) | 3 diff (99.5 %id) |
DA001044 | | .c | 10 to 515 | 2 to 508 | | capped | | 507/507 (100 %) | 1 diff (99.9 %id) |
DB085243 | testis | .c | 10 to 571 | 2 to 563 | | capped | | 562/562 (100 %) | 1 diff (99.9 %id) |
DA335146 | hippocampus | .c | 13 to 603 | 2 to 592 | | capped | | 591/591 (100 %) | 0 diff (100 %id) |
DA240742 | brain | .c | 14 to 550 | 2 to 538 | | capped | | 537/537 (100 %) | 1 diff (99.9 %id) |
DA244915 | brain | .c | 14 to 581 | 2 to 569 | | capped | | 568/568 (100 %) | 0 diff (100 %id) |
DB074671 | testis | .c | 14 to 545 | 2 to 533 | | capped | | 532/532 (100 %) | 1 diff (99.9 %id) |
DB089829 | testis | .c | 14 to 571 | 2 to 559 | | capped | | 558/558 (100 %) | 1 diff (99.9 %id) |
DB036563 | testis | .c | 15 to 590 | 2 to 577 | | capped | | 576/576 (100 %) | 0 diff (100 %id) |
DA222233 | brain | .c | 16 to 564 | 2 to 551 | | capped | | 550/550 (100 %) | 1 diff (99.9 %id) |
DA801158 | brain | .c | 16 to 560 | 2 to 546 | | capped | | 545/545 (100 %) | 1 diff (99.9 %id) |
DB092299 | testis | .c | 16 to 548 | 2 to 534 | | capped | | 533/533 (100 %) | 0 diff (100 %id) |
BX479728 | | .c | 17 to 467 | 1 to 451 | | | | 451/451 (100 %) | 3 diff (99.4 %id) |
DB237123 | trachea | .c | 18 to 572 | 2 to 557 | | capped | | 556/556 (100 %) | 2 diff (99.7 %id) |
DA120243 | cerebellum | .c | 19 to 573 | 2 to 556 | | capped | | 555/555 (100 %) | 1 diff (99.9 %id) |
DA183152 | amygdala | .c | 19 to 562 | 2 to 545 | | capped | | 544/544 (100 %) | 2 diff (99.7 %id) |
DA247321 | brain | .c | 19 to 614 | 2 to 597 | | capped | | 596/596 (100 %) | 0 diff (100 %id) |
DA445926 | tongue, tumor tissue | .c | 19 to 596 | 2 to 579 | | capped | | 578/578 (100 %) | 1 diff (99.9 %id) |
DA461386 | tongue, tumor tissue | .c | 19 to 591 | 2 to 574 | | capped | | 573/573 (100 %) | 1 diff (99.9 %id) |
DA857911 | placenta | .c | 19 to 564 | 2 to 547 | | capped | | 546/546 (100 %) | 1 diff (99.9 %id) |
DB093316 | testis | .c | 19 to 573 | 2 to 556 | | capped | | 555/555 (100 %) | 0 diff (100 %id) |
DB100229 | testis | .c | 19 to 601 | 2 to 584 | | capped | | 583/583 (100 %) | 0 diff (100 %id) |
DB140632 | thymus | .c | 19 to 572 | 2 to 555 | | capped | | 554/555 (99 %) | 2 diff (99.7 %id) |
DB144808 | thymus | .c | 19 to 557 | 2 to 540 | | capped | | 539/539 (100 %) | 2 diff (99.7 %id) |
DB219395 | trachea | .c | 19 to 560 | 2 to 542 | | capped | | 541/541 (100 %) | 1 diff (99.9 %id) |
DB240103 | trachea | .c | 19 to 587 | 2 to 570 | | capped | | 569/569 (100 %) | 0 diff (100 %id) |
BP871050 | embryonal kidney | .c | 21 to 351 | 1 to 331 | | | | 331/331 (100 %) | 4 diff (98.8 %id) |
DA720530 | | .c | 23 to 576 | 2 to 555 | | capped | | 554/554 (100 %) | 1 diff (99.9 %id) |
DB096303 | testis | .c | 23 to 564 | 2 to 543 | | capped | | 542/542 (100 %) | 1 diff (99.9 %id) |
DB165108 | thymus | .c | 23 to 611 | 2 to 590 | | capped | | 589/589 (100 %) | 0 diff (100 %id) |
DB185106 | liver, tumor tissue | .c | 23 to 593 | 2 to 573 | | capped | | 572/572 (100 %) | 1 diff (99.9 %id) |
DB237811 | trachea | .c | 23 to 501 | 2 to 480 | | capped | | 479/479 (100 %) | 0 diff (100 %id) |
CN362446 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .c | 25 to 264 | 1 to 240 | | | | 240/240 (100 %) | 0 diff (100 %id) |
DN915532 | | .c | 25 to 520 | 1 to 496 | | | | 496/496 (100 %) | 4 diff (99.2 %id) |
BQ893467 | dorsal root ganglia | .c | 25 to 886 | 1 to 865 | | | | 865/915 (94 %) | 5 diff (99.5 %id) |
DA218227 | brain | .c | 26 to 562 | 2 to 538 | | capped | | 537/537 (100 %) | 0 diff (100 %id) |
DA537739 | Kidney | .c | 26 to 591 | 2 to 567 | | capped | | 566/566 (100 %) | 1 diff (99.9 %id) |
CV807472 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .c | 26 to 676 | 1 to 658 | | | | 658/899 (73 %) | 27 diff (97.0 %id) |
DA623988 | Kidney | .c | 26 to 564 | 2 to 540 | | capped | | 539/539 (100 %) | 2 diff (99.7 %id) |
DA814483 | | .c | 26 to 550 | 2 to 526 | | capped | | 525/525 (100 %) | 1 diff (99.9 %id) |
DA520766 | brain | .c | 27 to 595 | 2 to 570 | | capped | | 569/569 (100 %) | 2 diff (99.7 %id) |
DA723782 | | .c | 27 to 567 | 2 to 542 | | capped | | 541/541 (100 %) | 0 diff (100 %id) |
DA735404 | | .c | 27 to 861 | 2 to 836 | | tiling clone, capped | | 835/837 (99 %) | 5 diff (99.5 %id) |
DA757304 | | .c | 27 to 577 | 2 to 552 | | capped | | 551/551 (100 %) | 1 diff (99.9 %id) |
DB076070 | testis | .c | 27 to 574 | 2 to 549 | | capped | | 548/548 (100 %) | 1 diff (99.9 %id) |
DB151052 | thymus | .c | 27 to 575 | 2 to 550 | | capped | | 549/549 (100 %) | 0 diff (100 %id) |
DB258086 | uterus | .c | 27 to 598 | 2 to 573 | | capped | | 572/572 (100 %) | 2 diff (99.7 %id) |
CX870237 | embryonic stem | .c | 47 to 952 | 1 to 906 | | | | 906/906 (100 %) | 4 diff (99.6 %id) |
BC012572 | Bone marrow, acute myelogenous leukemia | .c | 56 to 1640 | 1 to 1585 | | available from MGC, AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 1585/1628 (97 %) | 4 diff (99.8 %id) |
AU280499 | | .c | 58 to 630 | 1 to 573 | | | | 573/573 (100 %) | 2 diff (99.7 %id) |
BF241947 | bone marrow, from acute myelogenous leukemia | .c | 59 to 755 | 1 to 700 | | available from MGC, | | 700/882 (79 %) | 35 diff (96.1 %id) |
BP282239 | bone marrow | .c | 59 to 641 | 1 to 583 | | | | 583/583 (100 %) | 2 diff (99.7 %id) |
BP285501 | lung | .c | 59 to 639 | 1 to 581 | | | | 581/581 (100 %) | 0 diff (100 %id) |
DA724430 | | .c | 59 to 633 | 2 to 576 | | capped | | 575/575 (100 %) | 2 diff (99.7 %id) |
DA019050 | | .c | 60 to 615 | 2 to 557 | | capped | | 556/556 (100 %) | 1 diff (99.9 %id) |
DA034182 | | .c | 60 to 596 | 2 to 540 | | capped | | 539/539 (100 %) | 3 diff (99.5 %id) |
DA102668 | cerebellum | .c | 60 to 663 | 2 to 606 | | capped | | 605/605 (100 %) | 2 diff (99.7 %id) |
DA511031 | brain | .c | 60 to 640 | 2 to 582 | | capped | | 581/581 (100 %) | 2 diff (99.7 %id) |
DA549672 | | .c | 60 to 631 | 2 to 573 | | capped | | 572/572 (100 %) | 1 diff (99.9 %id) |
DA555240 | | .c | 60 to 627 | 2 to 570 | | capped | | 569/569 (100 %) | 3 diff (99.5 %id) |
DA805583 | brain | .c | 60 to 623 | 2 to 566 | | capped | | 565/565 (100 %) | 2 diff (99.7 %id) |
DA811372 | brain | .c | 60 to 620 | 2 to 564 | | capped | | 563/563 (100 %) | 3 diff (99.5 %id) |
DA852735 | placenta | .c | 60 to 609 | 2 to 551 | | capped | | 550/550 (100 %) | 1 diff (99.9 %id) |
DA978198 | synovial membrane tissue from rheumatioidarthritis | .c | 60 to 608 | 2 to 551 | | capped | | 550/550 (100 %) | 1 diff (99.9 %id) |
DB086243 | testis | .c | 60 to 320 | 2 to 264 | | capped | | 263/263 (100 %) | 3 diff (98.9 %id) |
DB089695 | testis | .c | 60 to 629 | 2 to 571 | | capped | | 570/570 (100 %) | 1 diff (99.9 %id) |
DB133667 | thymus | .c | 60 to 619 | 2 to 561 | | capped | | 560/560 (100 %) | 2 diff (99.7 %id) |
DB158903 | thymus | .c | 60 to 651 | 2 to 594 | | capped | | 593/595 (99 %) | 3 diff (99.5 %id) |
DB198528 | trachea | .c | 60 to 676 | 2 to 620 | | capped | | 619/622 (99 %) | 5 diff (99.2 %id) |
DB202308 | trachea | .c | 60 to 640 | 2 to 583 | | capped | | 582/582 (100 %) | 2 diff (99.7 %id) |
DB243287 | stomach, tumor tissue | .c | 60 to 625 | 2 to 568 | | capped | | 567/567 (100 %) | 3 diff (99.5 %id) |
DB227371 | trachea | .c | 61 to 410 | 2 to 351 | | capped | | 350/350 (100 %) | 2 diff (99.5 %id) |
AF111807 | aorta | .c | 73 to 3318 | 1 to 3246 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 3246/3246 (100 %) | 0 diff (100 %id) |
CN362454 | embryonic stem cells, cell lines H1, H7, andH9 | .c | 74 to 818 | 1 to 745 | | | | 745/745 (100 %) | 0 diff (100 %id) |
DB367670 | | .c | 2850 to 3318 | 472 to 1 | | | | 472/495 (95 %) | 11 diff (97.8 %id) |
AW015660 | | .d | 1 to 350 | 1 to 350 | | tiling clone, | Submitted on the opposite strand | 350/350 (100 %) | 1 diff (99.8 %id) |
NM_148976.2 | | .d | 1 to 1470 | 1 to 1470 | exact | RefSeq, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 1470/1470 (100 %) | 0 diff (100 %id) |
BX484474 | | .d | 5 to 243 | 1 to 238 | | | | 238/238 (100 %) | 3 diff (98.8 %id) |
A16796 | | .d | 18 to 1283 | 1 to 1264 | S20T P21A | | | 1264/1264 (100 %) | 6 diff (99.6 %id) |
M64992 | | .d | 18 to 1283 | 1 to 1264 | S20T P21A | | | 1264/1264 (100 %) | 6 diff (99.6 %id) |
CR612800 | neuroblastoma | .d | 229 to 1446 | 1 to 1218 | exact | tiling clone, | | 1218/1218 (100 %) | 0 diff (100 %id) |
FN077674 | breast carcinoma | .d | 361 to 446 | 1 to 92 | | | | 95/92 (103 %) | 8 diff (91.4 %id) |
AA303743 | aorta | .d | 366 to 699 | 7 to 340 | | | | 334/342 (97 %) | 7 diff (98.0 %id) |
CR598938 | Placenta Cot 25-normalized | .d | 366 to 1455 | 1 to 1090 | | | | 1090/1090 (100 %) | 0 diff (100 %id) |
CR599736 | HeLa cells Cot 25-normalized | .d | 366 to 1470 | 1 to 1105 | | tiling clone, | | 1105/1105 (100 %) | 0 diff (100 %id) |
BX399425 | Placenta Cot 25-normalized | .d | 366 to 938 | 1 to 573 | | fully sequenced, | | 573/573 (100 %) | 0 diff (100 %id) |
BG025840 | lymph, lymphoma, cell line | .d | 366 to 733 | 7 to 374 | | | | 368/374 (98 %) | 6 diff (98.4 %id) |
TI_1948085553 | | .d | 366 to 1154 | 128 to 919 | | | | 792/1368 (57 %) | 8 diff (99.5 %id) |
BT006647 | | .d | 367 to 1154 | 4 to 791 | | | | 791/792 (99 %) | 2 diff (99.8 %id) |
CV023488 | mixed | .d | 367 to 990 | 4 to 627 | | | | 627/627 (100 %) | 0 diff (100 %id) |
CA774907 | Pancreas, Purified pancreatic islet | .d | 368 to 727 | 1 to 360 | | | | 360/360 (100 %) | 0 diff (100 %id) |
BQ937816 | leiomyosarcoma, uterus | .d | 374 to 1166 | 1 to 796 | | | | 796/917 (86 %) | 26 diff (97.2 %id) |
AW020025 | cochlea, ear | .d | 384 to 830 | 2 to 448 | | fully sequenced, | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 447/448 (99 %) | 6 diff (98.7 %id) |
CN412701 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .d | 387 to 938 | 1 to 552 | | | | 552/552 (100 %) | 0 diff (100 %id) |
CX870871 | embryonic stem | .d | 395 to 1234 | 1 to 840 | | | | 840/840 (100 %) | 0 diff (100 %id) |
CD511447 | Blood vessels - aorta, basilar and artery | .d | 401 to 1098 | 1 to 700 | | | | 700/765 (91 %) | 7 diff (99.1 %id) |
TI_154194079 | | .d | 411 to 1344 | 68 to 998 | | | | 937/1132 (82 %) | 30 diff (97.4 %id) |
CB269879 | adipose | .d | 412 to 706 | 1 to 292 | | | | 292/296 (98 %) | 6 diff (98.0 %id) |
TI_149293607 | | .d | 508 to 1469 | 1038 to 84 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 955/1007 (94 %) | 29 diff (97.2 %id) |
BM798582 | myeloma | .d | 546 to 1045 | 1 to 500 | | | | 500/500 (100 %) | 0 diff (100 %id) |
BM832690 | stomach | .d | 570 to 1239 | 1 to 670 | | | | 670/670 (100 %) | 0 diff (100 %id) |
EH336586 | | .d | 581 to 656 | 1 to 76 | | | | 76/76 (100 %) | 0 diff (100 %id) |
BI834615 | pooled pancreas and spleen | .d | 597 to 1396 | 1 to 804 | | | | 804/804 (100 %) | 6 diff (99.3 %id) |
TI_57167801 | | .d | 597 to 1396 | 60 to 863 | | | | 804/863 (93 %) | 12 diff (98.7 %id) |
BF036151 | adenocarcinoma, ovary | .d | 599 to 1351 | 1 to 754 | | | | 754/879 (85 %) | 21 diff (97.7 %id) |
BM508995 | insulinoma, Pancreas | .d | 610 to 1184 | 8 to 582 | | | | 575/582 (98 %) | 0 diff (100 %id) |
CK905360 | insulinoma, Pancreas | .d | 610 to 1149 | 8 to 547 | | | | 540/547 (98 %) | 0 diff (100 %id) |
CB119710 | Liver | .d | 633 to 1060 | 1 to 428 | | | | 428/428 (100 %) | 0 diff (100 %id) |
CN412705 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .d | 638 to 1267 | 1 to 630 | | | | 630/630 (100 %) | 0 diff (100 %id) |
TI_153949599 | | .d | 641 to 1442 | 84 to 878 | | | | 795/1030 (77 %) | 39 diff (96.3 %id) |
CB162579 | Liver | .d | 648 to 1248 | 1 to 601 | | | | 601/601 (100 %) | 0 diff (100 %id) |
BE266400 | lung, small cell carcinoma | .d | 652 to 1323 | 1 to 670 | | | | 670/681 (98 %) | 4 diff (99.5 %id) |
BG571839 | placenta | .d | 655 to 1444 | 1 to 794 | | | | 794/1066 (74 %) | 29 diff (97.3 %id) |
CB126442 | Liver | .d | 655 to 878 | 1 to 224 | | | | 224/224 (100 %) | 0 diff (100 %id) |
BG183465 | | .d | 707 to 1460 | 753 to 8 | | | Submitted on the opposite strand | 746/866 (86 %) | 11 diff (98.8 %id) |
AV758818 | bone marrow | .d | 707 to 1411 | 74 to 772 | | AAA | | 699/819 (85 %) | 18 diff (97.9 %id) |
TI_154122507 | | .d | 710 to 1456 | 853 to 108 | | AAA | | 746/1065 (70 %) | 10 diff (99.1 %id) |
FN116679 | breast carcinoma | .d | 774 to 867 | 94 to 1 | | | Submitted on the opposite strand | 94/94 (100 %) | 0 diff (100 %id) |
EC584891 | Prostate | .d | 778 to 877 | 100 to 1 | | | | 100/100 (100 %) | 0 diff (100 %id) |
FN132879 | breast carcinoma | .d | 787 to 843 | 56 to 1 | | | Submitted on the opposite strand | 56/57 (98 %) | 1 diff (98.3 %id) |
EC493654 | Prostate | .d | 799 to 893 | 1 to 94 | | | | 94/94 (100 %) | 3 diff (96.9 %id) |
BI491050 | cochlea, ear | .d | 800 to 1470 | 689 to 19 | | fully sequenced, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 671/671 (100 %) | 0 diff (100 %id) |
FN096073 | breast carcinoma | .d | 801 to 881 | 1 to 76 | | | | 76/76 (100 %) | 4 diff (94.8 %id) |
DW411972 | Liver | .d | 806 to 1114 | 17 to 326 | | | | 310/326 (95 %) | 8 diff (97.6 %id) |
DW445873 | Liver | .d | 806 to 1008 | 17 to 219 | | | | 203/219 (92 %) | 6 diff (97.3 %id) |
BQ019314 | Chondrosarcoma, Left Pubic Bone | .d | 826 to 1470 | 663 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 645/645 (100 %) | 2 diff (99.7 %id) |
BM505629 | insulinoma, Pancreas | .d | 847 to 1470 | 639 to 16 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 624/624 (100 %) | 0 diff (100 %id) |
AW367446 | head_neck | .d | 872 to 1141 | 283 to 4 | | | | 280/286 (97 %) | 20 diff (93.1 %id) |
BX399424 | Placenta Cot 25-normalized | .d | 877 to 1455 | 576 to 1 | | fully sequenced, | | 576/576 (100 %) | 5 diff (99.2 %id) |
FN067068 | breast carcinoma | .d | 877 to 962 | 1 to 84 | | | | 84/95 (88 %) | 6 diff (93.7 %id) |
CA440765 | lung, Metastatic Chondrosarcoma | .d | 896 to 1470 | 593 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 575/575 (100 %) | 0 diff (100 %id) |
BU632892 | cell lines, Chondrosarcoma | .d | 896 to 1470 | 593 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 575/575 (100 %) | 0 diff (100 %id) |
BG655801 | Pancreas, Purified pancreatic islet | .d | 928 to 1460 | 587 to 54 | | AAA | Submitted on the opposite strand | 534/544 (98 %) | 0 diff (100 %id) |
EC440663 | Prostate | .d | 932 to 1028 | 97 to 1 | | | | 97/100 (97 %) | 5 diff (95.0 %id) |
EC452425 | Prostate | .d | 932 to 1028 | 97 to 1 | | | | 97/100 (97 %) | 5 diff (95.0 %id) |
EC532748 | Prostate | .d | 932 to 1019 | 88 to 1 | | | | 88/91 (96 %) | 5 diff (94.6 %id) |
EC532771 | Prostate | .d | 932 to 1019 | 87 to 1 | | | | 87/90 (96 %) | 8 diff (91.2 %id) |
EC576335 | Prostate | .d | 932 to 1019 | 87 to 1 | | | | 87/90 (96 %) | 8 diff (91.2 %id) |
EC576365 | Prostate | .d | 932 to 1019 | 85 to 1 | | | | 85/88 (96 %) | 10 diff (88.7 %id) |
FN172100 | breast carcinoma | .d | 933 to 1037 | 106 to 1 | | | Submitted on the opposite strand | 106/106 (100 %) | 1 diff (99.1 %id) |
EC459885 | Prostate | .d | 937 to 1018 | 81 to 1 | | | | 81/88 (92 %) | 7 diff (92.1 %id) |
EC541714 | Prostate | .d | 937 to 1038 | 102 to 1 | | | | 102/103 (99 %) | 2 diff (98.1 %id) |
BM148776 | leukopheresis | .d | 939 to 1469 | 548 to 17 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 532/533 (99 %) | 1 diff (99.9 %id) |
EC483782 | Prostate | .d | 941 to 1039 | 98 to 1 | | | | 98/100 (98 %) | 4 diff (96.0 %id) |
N41631 | placenta | .d | 957 to 1230 | 1 to 281 | | fully sequenced, | | 281/281 (100 %) | 0 diff (100 %id) |
EC572102 | Prostate | .d | 961 to 1058 | 98 to 1 | | | | 98/98 (100 %) | 0 diff (100 %id) |
EC475459 | Prostate | .d | 975 to 1070 | 98 to 4 | | | | 95/98 (96 %) | 0 diff (100 %id) |
EC475510 | Prostate | .d | 975 to 1075 | 100 to 1 | | | | 100/100 (100 %) | 3 diff (97.0 %id) |
BQ319087 | colon | .d | 979 to 1214 | 240 to 1 | | | | 240/277 (86 %) | 20 diff (92.8 %id) |
EC456091 | Prostate | .d | 993 to 1094 | 101 to 1 | | | | 101/101 (100 %) | 1 diff (99.1 %id) |
EC582697 | Prostate | .d | 1041 to 1132 | 93 to 3 | | | | 91/93 (97 %) | 1 diff (99.0 %id) |
FN120118 | breast carcinoma | .d | 1059 to 1146 | 87 to 1 | | | Submitted on the opposite strand | 87/92 (94 %) | 5 diff (94.6 %id) |
EC549712 | Prostate | .d | 1063 to 1156 | 94 to 1 | | | | 94/97 (96 %) | 0 diff (100 %id) |
EC463490 | Prostate | .d | 1066 to 1157 | 99 to 8 | | | | 92/99 (92 %) | 0 diff (100 %id) |
EC463967 | Prostate | .d | 1066 to 1162 | 96 to 2 | | | | 95/96 (98 %) | 1 diff (99.0 %id) |
EC481901 | Prostate | .d | 1066 to 1162 | 96 to 1 | | | | 96/96 (100 %) | 1 diff (99.0 %id) |
EC506914 | Prostate | .d | 1066 to 1158 | 97 to 7 | | | | 91/97 (93 %) | 1 diff (99.0 %id) |
EC507677 | Prostate | .d | 1066 to 1158 | 96 to 6 | | | | 91/96 (94 %) | 1 diff (99.0 %id) |
EC566239 | Prostate | .d | 1066 to 1159 | 97 to 5 | | | | 93/97 (95 %) | 1 diff (99.0 %id) |
EC579959 | Prostate | .d | 1066 to 1162 | 96 to 1 | | | | 96/96 (100 %) | 1 diff (99.0 %id) |
EC580666 | Prostate | .d | 1066 to 1157 | 102 to 12 | | | | 91/102 (89 %) | 1 diff (99.1 %id) |
EC508271 | Prostate | .d | 1069 to 1159 | 96 to 7 | | | | 90/100 (90 %) | 3 diff (97.0 %id) |
EC565368 | Prostate | .d | 1069 to 1157 | 97 to 11 | | | | 87/99 (87 %) | 3 diff (97.0 %id) |
EC493031 | Prostate | .d | 1077 to 1162 | 86 to 2 | | | | 85/94 (90 %) | 0 diff (100 %id) |
EC537120 | Prostate | .d | 1077 to 1162 | 85 to 1 | | | | 85/95 (89 %) | 5 diff (94.8 %id) |
AA216417 | | .d | 1094 to 1460 | 421 to 55 | | AAA | | 367/376 (97 %) | 0 diff (100 %id) |
EC553396 | Prostate | .d | 1098 to 1184 | 87 to 1 | | | | 87/87 (100 %) | 0 diff (100 %id) |
EC563919 | Prostate | .d | 1098 to 1181 | 88 to 6 | | | | 83/88 (94 %) | 0 diff (100 %id) |
N29626 | placenta | .d | 1200 to 1470 | 271 to 1 | | fully sequenced, | | 271/271 (100 %) | 0 diff (100 %id) |
DC394852 | testis | .e | 1 to 547 | 1 to 548 | | tiling clone, | | 548/553 (99 %) | 4 diff (99.3 %id) |
NM_002786.3 | | .e | 252 to 1504 | 1 to 1253 | exact | RefSeq, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 1253/1253 (100 %) | 0 diff (100 %id) |
BM762812 | lymph node, stomach | .e | 264 to 848 | 1 to 585 | | | | 585/585 (100 %) | 0 diff (100 %id) |
BM843460 | lymph node, stomach | .e | 264 to 980 | 1 to 717 | | | | 717/717 (100 %) | 0 diff (100 %id) |
CF593506 | Human Placenta, placenta | .e | 290 to 1054 | 25 to 790 | | | | 766/790 (96 %) | 7 diff (99.2 %id) |
BG687202 | lung, mucoepidermoid carcinoma | .e | 291 to 1127 | 1 to 843 | | | | 841/889 (94 %) | 78 diff (91.3 %id) |
X61969 | | .e | 293 to 1504 | 1 to 1216 | exact | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 1216/1216 (100 %) | 8 diff (99.4 %id) |
BM763431 | myeloma | .e | 295 to 863 | 1 to 569 | | | | 569/569 (100 %) | 0 diff (100 %id) |
BM840130 | myeloma | .e | 295 to 827 | 1 to 533 | | | | 533/533 (100 %) | 0 diff (100 %id) |
BU943162 | mixed (pool of 40 RNAs) | .e | 300 to 1054 | 1 to 761 | | | | 759/770 (98 %) | 10 diff (98.8 %id) |
BI561071 | testis | .e | 306 to 1225 | 1 to 916 | E186G H190T G191W L192S R193A ... | | | 916/930 (98 %) | 26 diff (97.3 %id) |
BM468984 | duodenal adenocarcinoma, cell line, small intestine | .e | 308 to 914 | 1 to 608 | | | | 608/1040 (58 %) | 4 diff (99.7 %id) |
BU570948 | brain, glioblastoma | .e | 308 to 1128 | 1 to 823 | | | | 823/824 (99 %) | 12 diff (98.6 %id) |
BI550035 | brain, hippocampus | .e | 310 to 1130 | 1 to 820 | | | | 820/864 (94 %) | 7 diff (99.2 %id) |
DA893629 | skeletal muscle | .e | 310 to 866 | 2 to 558 | | capped | | 557/557 (100 %) | 0 diff (100 %id) |
DA967066 | stomach | .e | 310 to 884 | 2 to 576 | | capped | | 575/575 (100 %) | 0 diff (100 %id) |
AK290765 | | .e | 311 to 1252 | 1 to 942 | exact | | | 942/942 (100 %) | 1 diff (99.9 %id) |
TI_44349306 | | .e | 311 to 1225 | 88 to 998 | E186G H190T G191W L192S R193A ... | | | 911/1012 (90 %) | 28 diff (97.3 %id) |
CB141270 | Liver | .e | 311 to 936 | 1 to 626 | | | | 626/626 (100 %) | 0 diff (100 %id) |
BM850068 | myeloma | .e | 311 to 914 | 1 to 604 | | | | 604/604 (100 %) | 0 diff (100 %id) |
BM829737 | stomach | .e | 311 to 849 | 1 to 539 | | | | 539/539 (100 %) | 0 diff (100 %id) |
CB986028 | Pooled-Glandular | .e | 312 to 1077 | 1 to 773 | | | | 773/780 (99 %) | 15 diff (98.1 %id) |
BG436224 | placenta | .e | 314 to 1132 | 1 to 821 | | | | 823/863 (95 %) | 19 diff (97.8 %id) |
TI_44169734 | | .e | 315 to 1130 | 91 to 905 | | | | 815/949 (85 %) | 8 diff (99.2 %id) |
CB118451 | Liver | .e | 315 to 935 | 1 to 621 | | | | 621/621 (100 %) | 0 diff (100 %id) |
BM837375 | Ascites, stomach | .e | 315 to 945 | 1 to 631 | | | | 631/631 (100 %) | 0 diff (100 %id) |
BC005932 | Bone marrow, acute myelogenous leukemia | .e | 317 to 1502 | 1 to 1186 | G37V | available from MGC, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 1186/1188 (99 %) | 2 diff (99.9 %id) |
BG429711 | Kidney | .e | 318 to 945 | 1 to 630 | | | | 630/817 (77 %) | 7 diff (99.2 %id) |
TI_57240689 | | .e | 318 to 1093 | 28 to 804 | | | | 777/806 (96 %) | 9 diff (98.9 %id) |
CN412697 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .e | 321 to 950 | 1 to 630 | | | | 630/630 (100 %) | 0 diff (100 %id) |
BG533775 | Liver | .e | 321 to 1117 | 1 to 798 | | | | 798/799 (99 %) | 23 diff (97.2 %id) |
BI914693 | brain | .e | 321 to 1093 | 1 to 774 | | | | 774/776 (99 %) | 3 diff (99.7 %id) |
BM548887 | duodenal adenocarcinoma, cell line, small intestine | .e | 321 to 1241 | 1 to 937 | N185X L233P E234G G235R L236V ... | | | 937/1042 (89 %) | 23 diff (97.8 %id) |
BC015105 | Prostate | .e | 322 to 1505 | 5 to 1188 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 1184/1185 (99 %) | 2 diff (99.9 %id) |
CR623849 | neuroblastoma | .e | 323 to 1478 | 1 to 1156 | exact | | | 1156/1156 (100 %) | 0 diff (100 %id) |
AL516500 | brain, neuroblastoma, neuroblastoma cells | .e | 323 to 1052 | 1 to 729 | | fully sequenced, | | 729/729 (100 %) | 0 diff (100 %id) |
BQ277046 | mixed (pool of 40 RNAs) | .e | 326 to 1133 | 1 to 817 | | | | 817/906 (90 %) | 17 diff (98.2 %id) |
BI260138 | cervical carcinoma cell line, cervix | .e | 327 to 1132 | 1 to 807 | | | | 807/816 (98 %) | 10 diff (98.8 %id) |
FN078510 | breast carcinoma | .e | 329 to 400 | 75 to 4 | | | Submitted on the opposite strand | 72/79 (91 %) | 0 diff (100 %id) |
BQ230174 | melanotic melanoma, skin | .e | 329 to 1125 | 1 to 809 | | | | 809/865 (93 %) | 20 diff (97.7 %id) |
CN412704 | embryonic stem cells, DMSO-treated H9 cellline | .e | 331 to 611 | 1 to 281 | | | | 281/281 (100 %) | 0 diff (100 %id) |
DT216881 | brain | .e | 332 to 982 | 1 to 651 | | | | 651/651 (100 %) | 0 diff (100 %id) |
BG290441 | bladder, transitional cell papilloma, cell line | .e | 332 to 1098 | 1 to 771 | | | | 769/850 (90 %) | 25 diff (97.1 %id) |
CB116874 | Liver | .e | 332 to 599 | 1 to 268 | | | | 268/268 (100 %) | 0 diff (100 %id) |
BC002577 | Ovary, adenocarcinoma | .e | 333 to 1504 | 1 to 1172 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 1172/1172 (100 %) | 0 diff (100 %id) |
BG258923 | embryonal carcinoma, cell line, testis | .e | 333 to 1128 | 1 to 795 | | | | 793/838 (94 %) | 21 diff (97.5 %id) |
BI759865 | pooled colon, kidney, stomach | .e | 333 to 1163 | 1 to 827 | | | | 827/827 (100 %) | 9 diff (99.0 %id) |
BI765274 | pooled colon, kidney, stomach | .e | 333 to 1132 | 1 to 799 | | | | 799/854 (93 %) | 6 diff (99.3 %id) |
BU172424 | melanotic melanoma, skin | .e | 333 to 1102 | 12 to 791 | | | | 780/854 (91 %) | 21 diff (97.6 %id) |
TI_57148631 | | .e | 333 to 1163 | 67 to 893 | | | | 827/893 (92 %) | 15 diff (98.4 %id) |
TI_57152264 | | .e | 333 to 1132 | 31 to 829 | | | | 799/884 (90 %) | 11 diff (98.8 %id) |
DA893530 | skeletal muscle | .e | 333 to 898 | 2 to 567 | | capped | | 566/566 (100 %) | 0 diff (100 %id) |
DB279399 | uterus | .e | 333 to 882 | 2 to 551 | | capped | | 550/550 (100 %) | 0 diff (100 %id) |
CR607412 | placenta | .e | 334 to 1498 | 1 to 1165 | exact | | | 1165/1165 (100 %) | 0 diff (100 %id) |
BX459242 | placenta | .e | 334 to 1052 | 1 to 719 | | fully sequenced, | | 719/719 (100 %) | 0 diff (100 %id) |
CA941146 | Pancreas, Purified pancreatic islet | .e | 334 to 949 | 1 to 616 | | fully sequenced, | | 616/616 (100 %) | 0 diff (100 %id) |
BU596316 | mixed (pool of 40 RNAs) | .e | 335 to 1133 | 1 to 801 | | | | 801/813 (98 %) | 22 diff (97.3 %id) |
DA613479 | | .e | 335 to 901 | 2 to 568 | | capped | | 567/567 (100 %) | 0 diff (100 %id) |
CB154871 | brain | .e | 341 to 982 | 1 to 642 | | | | 642/642 (100 %) | 0 diff (100 %id) |
CR617103 | Placenta Cot 25-normalized | .e | 341 to 1469 | 1 to 1129 | exact | | | 1129/1129 (100 %) | 0 diff (100 %id) |
BX380387 | Placenta Cot 25-normalized | .e | 341 to 972 | 1 to 632 | | fully sequenced, | | 632/632 (100 %) | 1 diff (99.9 %id) |
DT219680 | brain | .e | 341 to 980 | 1 to 640 | | | | 640/640 (100 %) | 0 diff (100 %id) |
BQ277373 | mixed (pool of 40 RNAs) | .e | 341 to 1094 | 1 to 762 | | | | 762/930 (81 %) | 18 diff (98.1 %id) |
BM828424 | stomach | .e | 341 to 982 | 1 to 642 | | | | 642/642 (100 %) | 0 diff (100 %id) |
DA119502 | cerebellum | .e | 342 to 877 | 2 to 537 | | capped | | 536/536 (100 %) | 0 diff (100 %id) |
CN412698 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .e | 342 to 765 | 1 to 424 | | | | 424/424 (100 %) | 0 diff (100 %id) |
DA436694 | tongue, tumor tissue | .e | 342 to 914 | 2 to 574 | | capped | | 573/573 (100 %) | 0 diff (100 %id) |
BQ434925 | leiomyosarcoma, uterus | .e | 342 to 1216 | 5 to 880 | G235S E237* | | | 876/881 (99 %) | 15 diff (98.3 %id) |
AU129708 | | .e | 342 to 1047 | 2 to 720 | | fully sequenced, capped | | 719/719 (100 %) | 33 diff (95.5 %id) |
DA893043 | skeletal muscle | .e | 342 to 866 | 2 to 526 | | capped | | 525/525 (100 %) | 0 diff (100 %id) |
DA894194 | skeletal muscle | .e | 342 to 883 | 2 to 543 | | capped | | 542/542 (100 %) | 0 diff (100 %id) |
DB229038 | trachea | .e | 342 to 929 | 2 to 589 | | capped | | 588/588 (100 %) | 0 diff (100 %id) |
BG687068 | lung, mucoepidermoid carcinoma | .e | 343 to 1132 | 1 to 795 | | | | 795/866 (91 %) | 15 diff (98.3 %id) |
BP871010 | embryonal kidney | .e | 344 to 675 | 1 to 332 | | | | 332/332 (100 %) | 0 diff (100 %id) |
BC009576 | Bone marrow, acute myelogenous leukemia | .e | 344 to 1274 | 1 to 931 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 931/931 (100 %) | 0 diff (100 %id) |
CB142347 | Liver | .e | 344 to 864 | 1 to 521 | | | | 521/521 (100 %) | 0 diff (100 %id) |
DA896182 | skeletal muscle | .e | 345 to 884 | 2 to 541 | | capped | | 540/540 (100 %) | 0 diff (100 %id) |
CX788060 | human embryonic stem cells | .e | 346 to 974 | 1 to 629 | | | | 629/629 (100 %) | 0 diff (100 %id) |
TI_57236848 | | .e | 347 to 1217 | 66 to 949 | Q16X I212M G213W I214N V215C ... | | | 884/952 (92 %) | 26 diff (97.3 %id) |
BI910926 | leukocyte | .e | 348 to 1217 | 1 to 883 | Q16X I212M G213W I214N V215C ... | | | 883/886 (99 %) | 20 diff (97.8 %id) |
BC015356 | Placenta, choriocarcinoma | .e | 349 to 1500 | 1 to 1152 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 1152/1152 (100 %) | 0 diff (100 %id) |
BI088638 | cervix | .e | 349 to 1138 | 1 to 792 | | | | 792/881 (89 %) | 15 diff (98.3 %id) |
BU162749 | large cell carcinoma, lung | .e | 350 to 1237 | 1 to 898 | C182R V188L D204E L205P T206D ... | | | 898/899 (99 %) | 27 diff (97.0 %id) |
BM729140 | eye, fetal eye | .e | 350 to 981 | 1 to 635 | | fully sequenced, | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 635/635 (100 %) | 9 diff (98.6 %id) |
BC008472 | Brain, primitive neuroectodermal | .e | 352 to 1500 | 1 to 1149 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 1149/1149 (100 %) | 0 diff (100 %id) |
DT216390 | brain | .e | 352 to 982 | 1 to 631 | | | | 631/631 (100 %) | 0 diff (100 %id) |
CR599649 | Placenta Cot 25-normalized | .e | 355 to 1487 | 1 to 1133 | exact | | | 1133/1133 (100 %) | 0 diff (100 %id) |
BG403613 | bladder, transitional cell papilloma, cell line | .e | 356 to 1129 | 1 to 768 | | | | 768/972 (79 %) | 16 diff (98.4 %id) |
BG696662 | skin | .e | 356 to 1134 | 1 to 777 | | | | 777/818 (94 %) | 11 diff (98.7 %id) |
CA771306 | Pancreas, Purified pancreatic islet | .e | 356 to 832 | 11 to 487 | | | | 477/487 (97 %) | 6 diff (98.8 %id) |
CR986523 | T-Lymphocytes | .e | 356 to 1214 | 1 to 859 | exact | | | 859/859 (100 %) | 0 diff (100 %id) |
CR610121 | Placenta Cot 25-normalized | .e | 357 to 1500 | 1 to 1144 | exact | | | 1144/1144 (100 %) | 0 diff (100 %id) |
BX382590 | Placenta Cot 25-normalized | .e | 357 to 1052 | 1 to 696 | | fully sequenced, | | 696/696 (100 %) | 2 diff (99.8 %id) |
D00759 | | .e | 357 to 1461 | 1 to 1105 | exact | | | 1105/1105 (100 %) | 0 diff (100 %id) |
BI829422 | brain, medulla | .e | 357 to 1115 | 1 to 760 | | | | 760/760 (100 %) | 15 diff (98.1 %id) |
BU508915 | leiomyosarcoma, uterus | .e | 357 to 1130 | 1 to 775 | | | | 775/889 (87 %) | 13 diff (98.6 %id) |
BQ919470 | carcinoma, cell line, Prostate | .e | 358 to 1278 | 1 to 925 | E237G Q241R R242E K243R A244H ... | | | 925/955 (96 %) | 22 diff (97.7 %id) |
BU541737 | carcinoma, cell line, Prostate | .e | 358 to 1010 | 1 to 658 | | | | 658/1053 (62 %) | 7 diff (99.4 %id) |
BM833268 | stomach | .e | 358 to 957 | 1 to 600 | | | | 600/600 (100 %) | 0 diff (100 %id) |
BI837712 | pooled pancreas and spleen | .e | 359 to 1234 | 1 to 867 | G17A R18G I19F H20I Q21K ... | | | 867/875 (99 %) | 25 diff (97.2 %id) |
CB128070 | Liver | .e | 359 to 931 | 1 to 573 | | | | 573/573 (100 %) | 0 diff (100 %id) |
BX404374 | neuroblastoma | .e | 360 to 1052 | 1 to 693 | | fully sequenced, | | 693/693 (100 %) | 1 diff (99.9 %id) |
CN412685 | embryonic stem cells, cell lines H1, H7, andH9 | .e | 360 to 1131 | 8 to 778 | | | | 771/778 (99 %) | 6 diff (99.3 %id) |
CR597642 | neuroblastoma | .e | 360 to 1502 | 1 to 1143 | exact | | | 1143/1143 (100 %) | 0 diff (100 %id) |
CR620774 | Placenta Cot 25-normalized | .e | 360 to 1505 | 1 to 1146 | exact | tiling clone, | | 1146/1146 (100 %) | 0 diff (100 %id) |
BX379166 | Placenta Cot 25-normalized | .e | 360 to 1469 | 1 to 1096 | exact | fully sequenced, | | 1096/1096 (100 %) | 25 diff (97.8 %id) |
BG168097 | hypernephroma, cell line, Kidney | .e | 360 to 1127 | 1 to 762 | | | | 762/912 (83 %) | 14 diff (98.5 %id) |
BM456362 | lymph, lymphoma, cell line | .e | 361 to 1209 | 1 to 857 | I63N L64S H65P V66C D67* | | | 857/857 (100 %) | 17 diff (98.1 %id) |
BC022372 | placenta | .e | 365 to 1504 | 1 to 1140 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 1140/1140 (100 %) | 0 diff (100 %id) |
CN412694 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .e | 365 to 1079 | 1 to 716 | | | | 716/716 (100 %) | 1 diff (99.9 %id) |
AA312808 | | .e | 367 to 863 | 1 to 497 | | | | 497/497 (100 %) | 0 diff (100 %id) |
CR999331 | T-Lymphocytes | .e | 368 to 1207 | 1 to 842 | D218E E220G F221V T222Y I223N ... | | | 842/842 (100 %) | 3 diff (99.7 %id) |
BE886824 | leiomyosarcoma, uterus | .e | 369 to 1132 | 1 to 764 | | | | 764/876 (87 %) | 13 diff (98.6 %id) |
BU173398 | leiomyosarcoma, uterus | .e | 370 to 1261 | 1 to 897 | L233X E234G G235R L236S E237X ... | | | 897/898 (99 %) | 9 diff (99.0 %id) |
BQ962259 | leiomyosarcoma, uterus | .e | 370 to 1187 | 1 to 826 | | | | 823/850 (96 %) | 15 diff (98.3 %id) |
BM564879 | eye, retinoblastoma | .e | 371 to 1311 | 10 to 959 | V188X S211F I212P G213L I214E ... | | | 950/1009 (94 %) | 34 diff (96.7 %id) |
BM449703 | melanotic melanoma, skin | .e | 372 to 1243 | 1 to 881 | E238R R239K P240T Q241T R242E ... | | | 881/885 (99 %) | 12 diff (98.7 %id) |
DR156078 | human embryonic stem cells differentiated toan early endodermal cell type | .e | 373 to 1097 | 1 to 725 | | | | 725/725 (100 %) | 0 diff (100 %id) |
BP424191 | small intestine | .e | 374 to 885 | 1 to 512 | | | Submitted on the opposite strand | 512/512 (100 %) | 0 diff (100 %id) |
CT001239 | T-Lymphocytes | .e | 374 to 1052 | 1 to 679 | | | | 679/679 (100 %) | 0 diff (100 %id) |
CR976308 | T-Lymphocytes | .e | 374 to 1179 | 1 to 813 | | | | 813/822 (98 %) | 12 diff (98.6 %id) |
BM907870 | large cell carcinoma, lung | .e | 375 to 1208 | 35 to 876 | V188L E202Q Q203H Q241P R242T ... | | | 842/1087 (77 %) | 25 diff (97.8 %id) |
DA107338 | cerebellum | .e | 376 to 918 | 2 to 544 | | capped | | 543/543 (100 %) | 0 diff (100 %id) |
CX788593 | human embryonic stem cells | .e | 377 to 1270 | 1 to 894 | P260T | | | 894/894 (100 %) | 3 diff (99.7 %id) |
BY795515 | eye | .e | 379 to 975 | 1 to 597 | | | | 597/597 (100 %) | 0 diff (100 %id) |
CN412682 | embryonic stem cells, DMSO-treated H9 cellline | .e | 380 to 837 | 1 to 458 | | | | 458/458 (100 %) | 0 diff (100 %id) |
BE543308 | cervical carcinoma cell line, cervix | .e | 380 to 1125 | 1 to 751 | | | | 751/981 (76 %) | 34 diff (96.6 %id) |
BG674421 | skin | .e | 380 to 1129 | 1 to 752 | | | | 752/832 (90 %) | 7 diff (99.2 %id) |
CR995548 | T-Lymphocytes | .e | 380 to 1293 | 1 to 914 | E234X G235R L236S E237* | | | 914/916 (99 %) | 4 diff (99.6 %id) |
BE886082 | leiomyosarcoma, uterus | .e | 382 to 1132 | 1 to 752 | | | | 752/876 (85 %) | 16 diff (98.2 %id) |
BG252999 | adenocarcinoma, cell line, Liver | .e | 383 to 1132 | 1 to 753 | | | | 753/814 (92 %) | 21 diff (97.5 %id) |
CN412686 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .e | 384 to 954 | 1 to 571 | | | | 571/571 (100 %) | 0 diff (100 %id) |
CN412699 | embryonic stem cells, cell lines H1, H7, andH9 | .e | 384 to 992 | 1 to 609 | | | | 609/609 (100 %) | 0 diff (100 %id) |
BU662593 | blood | .e | 395 to 1045 | 1 to 651 | | | | 651/651 (100 %) | 0 diff (100 %id) |
CA454631 | | .e | 452 to 1325 | 1 to 877 | | | | 877/881 (99 %) | 8 diff (99.1 %id) |
BM699046 | eye, fetal eyes | .e | 488 to 1052 | 1 to 564 | | fully sequenced, | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 564/564 (100 %) | 0 diff (100 %id) |
BM925835 | brain | .e | 489 to 1503 | 1 to 1017 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 1017/1019 (99 %) | 16 diff (98.5 %id) |
CA866176 | Pancreas, Purified pancreatic islet | .e | 908 to 1503 | 600 to 5 | | fully sequenced, | | 596/600 (99 %) | 0 diff (100 %id) |
BX379165 | Placenta Cot 25-normalized | .e | 911 to 1488 | 577 to 1 | | fully sequenced, | | 577/577 (100 %) | 11 diff (98.1 %id) |
BX380386 | Placenta Cot 25-normalized | .e | 911 to 1469 | 558 to 1 | | fully sequenced, | | 558/558 (100 %) | 6 diff (99.0 %id) |
BM682067 | eye, fetal eye | .e | 959 to 1504 | 564 to 19 | | fully sequenced, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 546/546 (100 %) | 0 diff (100 %id) |
BX433874 | neuroblastoma | .e | 991 to 1502 | 511 to 1 | | fully sequenced, | | 511/511 (100 %) | 3 diff (99.5 %id) |
AL516499 | brain, neuroblastoma, neuroblastoma cells | .e | 991 to 1478 | 489 to 1 | | fully sequenced, | | 489/489 (100 %) | 3 diff (99.4 %id) |
BX412498 | placenta | .e | 991 to 1498 | 505 to 1 | | fully sequenced, | | 505/505 (100 %) | 9 diff (98.3 %id) |
BX330727 | Placenta Cot 25-normalized | .e | 991 to 1500 | 507 to 1 | | fully sequenced, | | 507/507 (100 %) | 6 diff (98.9 %id) |
AU151785 | | .e | 991 to 1504 | 511 to 1 | | fully sequenced, | | 511/511 (100 %) | 2 diff (99.7 %id) |
BM669348 | eye, fetal eyes | .e | 991 to 1504 | 531 to 19 | | fully sequenced, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 513/513 (100 %) | 2 diff (99.7 %id) |
CA771006 | Pancreas, Purified pancreatic islet | .e | 1057 to 1503 | 447 to 1 | | | | 447/447 (100 %) | 0 diff (100 %id) |
AA879035 | metastatic prostate bone lesion | .e | 1196 to 1505 | 315 to 3 | | | | 313/315 (99 %) | 0 diff (100 %id) |
BF755296 | colon | .e | 1234 to 1499 | 268 to 6 | | | Submitted on the opposite strand | 263/268 (98 %) | 0 diff (100 %id) |
FN139510 | breast carcinoma | .e | 1246 to 1343 | 99 to 1 | | | Submitted on the opposite strand | 99/100 (99 %) | 1 diff (99.0 %id) |
BM842028 | lymph node, stomach | .e | 1301 to 1504 | 1 to 204 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 204/204 (100 %) | 0 diff (100 %id) |
FN059001 | breast carcinoma | .e | 1333 to 1438 | 1 to 106 | | | | 106/106 (100 %) | 0 diff (100 %id) |
AW496814 | | .e | 1345 to 1479 | 135 to 1 | | | | 135/135 (100 %) | 0 diff (100 %id) |
EC565320 | Prostate | .e | 1357 to 1475 | 119 to 1 | | | | 119/119 (100 %) | 0 diff (100 %id) |
FN175170 | breast carcinoma | .e | 1423 to 1501 | 86 to 5 | | | Submitted on the opposite strand | 82/86 (95 %) | 0 diff (100 %id) |
DW434894 | Liver | .f | 1 to 241 | 17 to 257 | | tiling clone, | | 241/257 (93 %) | 6 diff (97.7 %id) |
CN412691 | embryonic stem cells, DMSO-treated H9 cellline | .f | 21 to 564 | 1 to 544 | | | | 544/544 (100 %) | 0 diff (100 %id) |
BU928894 | brain, glioblastoma | .f | 22 to 864 | 1 to 836 | A156S S158X Q159P N176I L180T ... | | | 836/907 (92 %) | 35 diff (96.2 %id) |
BM452677 | lymph, lymphoma, cell line | .f | 35 to 806 | 1 to 772 | R189K E190K E231R Q234P A240G ... | tiling clone, | | 915/982 (93 %) | 29 diff (97.1 %id) |
BM787436 | stomach | .f | 38 to 656 | 1 to 619 | | | | 619/619 (100 %) | 0 diff (100 %id) |
BM555134 | duodenal adenocarcinoma, cell line, small intestine | .f | 62 to 885 | 1 to 825 | Q234P | tiling clone, | | 825/1070 (77 %) | 8 diff (99.3 %id) |
BU553467 | ovary, teratocarcinoma, cell line | .f | 63 to 873 | 1 to 812 | G228S P233H Q234R R235E K236R ... | tiling clone, | | 812/899 (90 %) | 8 diff (99.2 %id) |
BE826092 | lung_normal | .f | 122 to 364 | 247 to 1 | | | | 247/247 (100 %) | 2 diff (99.2 %id) |
DA053703 | | .g | 1 to 491 | 2 to 492 | | capped | | 491/491 (100 %) | 0 diff (100 %id) |
DA175417 | amygdala | .g | 1 to 563 | 2 to 564 | | tiling clone, capped | | 563/563 (100 %) | 0 diff (100 %id) |
CR607472 | Neuroblastoma Cot 10-normalized | .g | 2 to 1528 | 1 to 1527 | exact | tiling clone, | | 1527/1527 (100 %) | 0 diff (100 %id) |
AL521324 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .g | 2 to 831 | 1 to 830 | | fully sequenced, | | 830/830 (100 %) | 1 diff (99.9 %id) |
BG702887 | brain, hippocampus | .g | 4 to 761 | 1 to 761 | | | | 761/762 (99 %) | 15 diff (98.1 %id) |
DA613624 | | .g | 8 to 602 | 2 to 596 | | capped | | 595/595 (100 %) | 0 diff (100 %id) |
DA082267 | cerebellum | .g | 10 to 573 | 2 to 565 | | capped | | 564/564 (100 %) | 0 diff (100 %id) |
DA134985 | alzheimer cortex | .g | 10 to 569 | 2 to 561 | | capped | | 560/560 (100 %) | 0 diff (100 %id) |
DA364451 | subthalamic nucleus | .g | 10 to 550 | 2 to 542 | | capped | | 541/541 (100 %) | 0 diff (100 %id) |
DA364462 | subthalamic nucleus | .g | 10 to 505 | 2 to 497 | | capped | | 496/496 (100 %) | 1 diff (99.8 %id) |
DA616882 | | .g | 10 to 606 | 2 to 598 | | capped | | 597/597 (100 %) | 2 diff (99.7 %id) |
DA932781 | Spleen | .g | 10 to 575 | 2 to 567 | | capped | | 566/566 (100 %) | 0 diff (100 %id) |
DB111404 | thymus | .g | 10 to 585 | 2 to 577 | | capped | | 576/576 (100 %) | 1 diff (99.9 %id) |
BM149459 | leukopheresis | .g | 11 to 519 | 1 to 509 | | | | 509/509 (100 %) | 4 diff (99.3 %id) |
DA058276 | cerebellum | .g | 13 to 587 | 2 to 576 | | capped | | 575/575 (100 %) | 0 diff (100 %id) |
DA378941 | thalamus | .g | 13 to 566 | 2 to 555 | | capped | | 554/554 (100 %) | 0 diff (100 %id) |
DB039874 | testis | .g | 13 to 586 | 2 to 576 | | capped | | 575/575 (100 %) | 1 diff (99.9 %id) |
DB124070 | thymus | .g | 14 to 583 | 2 to 571 | | capped | | 570/570 (100 %) | 0 diff (100 %id) |
BI199257 | brain, neuroblastoma | .g | 15 to 707 | 1 to 702 | | | | 702/1033 (67 %) | 18 diff (98.3 %id) |
BM924932 | pooled lung and spleen | .g | 18 to 979 | 13 to 985 | | | | 949/1079 (87 %) | 19 diff (98.3 %id) |
DA061768 | cerebellum | .g | 21 to 553 | 2 to 535 | | capped | | 534/534 (100 %) | 1 diff (99.9 %id) |
DA356981 | subthalamic nucleus | .g | 21 to 574 | 2 to 557 | | capped | | 556/556 (100 %) | 2 diff (99.7 %id) |
DA378937 | thalamus | .g | 22 to 571 | 2 to 551 | | capped | | 550/550 (100 %) | 0 diff (100 %id) |
BG752683 | eye, normal pigmented retinal epithelium | .g | 27 to 800 | 1 to 772 | | | | 772/775 (99 %) | 5 diff (99.4 %id) |
CX760302 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .g | 27 to 752 | 1 to 726 | | | | 726/726 (100 %) | 0 diff (100 %id) |
AU310869 | neuroblastoma | .g | 27 to 604 | 1 to 578 | | | | 578/578 (100 %) | 0 diff (100 %id) |
DA137262 | alzheimer cortex | .g | 28 to 593 | 2 to 567 | | capped | | 566/566 (100 %) | 1 diff (99.9 %id) |
DA150336 | amygdala | .g | 28 to 595 | 2 to 574 | | capped | | 573/573 (100 %) | 9 diff (98.5 %id) |
DA562039 | heart | .g | 28 to 597 | 2 to 571 | | capped | | 570/570 (100 %) | 0 diff (100 %id) |
DA616831 | | .g | 28 to 602 | 2 to 576 | | capped | | 575/575 (100 %) | 1 diff (99.9 %id) |
DB004998 | breast, tumor tissue | .g | 28 to 564 | 2 to 539 | | capped | | 538/538 (100 %) | 1 diff (99.9 %id) |
DB109613 | thymus | .g | 28 to 602 | 2 to 577 | | capped | | 576/576 (100 %) | 1 diff (99.9 %id) |
DA606117 | | .g | 29 to 519 | 60 to 550 | | capped | | 491/549 (89 %) | 6 diff (99.0 %id) |
BM914344 | Spleen | .g | 36 to 870 | 1 to 839 | | | | 839/1016 (82 %) | 11 diff (99.0 %id) |
AL705117 | human skeletal muscle | .g | 38 to 546 | 1 to 509 | | | | 509/510 (99 %) | 4 diff (99.3 %id) |
BQ933282 | large cell carcinoma, lung | .g | 39 to 967 | 16 to 947 | | | | 932/947 (98 %) | 21 diff (97.8 %id) |
BG331809 | large cell carcinoma, lung | .g | 44 to 800 | 1 to 754 | | | | 754/988 (76 %) | 32 diff (96.8 %id) |
DR159273 | human embryonic stem cells differentiated toan early endodermal cell type | .g | 46 to 859 | 1 to 814 | | | | 814/814 (100 %) | 1 diff (99.9 %id) |
BE791639 | lung, small cell carcinoma | .g | 51 to 790 | 1 to 731 | | | | 731/943 (77 %) | 21 diff (97.8 %id) |
BF036892 | adenocarcinoma, ovary | .g | 59 to 673 | 1 to 616 | | | | 616/616 (100 %) | 1 diff (99.9 %id) |
BF036052 | adenocarcinoma, ovary | .g | 64 to 719 | 1 to 660 | | | | 660/898 (73 %) | 24 diff (97.4 %id) |
BY997341 | | .g | 90 to 787 | 10 to 707 | | | | 698/707 (98 %) | 6 diff (99.2 %id) |
H23509 | whole brain | .g | 98 to 506 | 1 to 411 | | | Submitted on the opposite strand | 411/412 (99 %) | 12 diff (97.1 %id) |
CN412709 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .g | 178 to 827 | 1 to 650 | | | | 650/650 (100 %) | 5 diff (99.3 %id) |
BM763187 | myeloma | .g | 263 to 891 | 1 to 628 | | | | 628/628 (100 %) | 1 diff (99.9 %id) |
DA860442 | placenta | .g | 264 to 833 | 2 to 571 | | capped | | 570/570 (100 %) | 0 diff (100 %id) |
BQ339403 | nervous_normal | .g | 372 to 971 | 610 to 13 | | | | 598/610 (98 %) | 11 diff (98.2 %id) |
AL521323 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .g | 770 to 1528 | 759 to 1 | | fully sequenced, | | 759/759 (100 %) | 0 diff (100 %id) |
H23538 | whole brain | .g | 1163 to 1564 | 432 to 18 | | tiling clone, AAA | Submitted on the opposite strand | 415/421 (98 %) | 19 diff (95.5 %id) |
DA000225 | | .h | 1 to 499 | 5 to 503 | | tiling clone, capped | | 502/502 (100 %) | 0 diff (100 %id) |
DA847618 | placenta | .h | 1 to 419 | 5 to 423 | | capped | | 422/422 (100 %) | 0 diff (100 %id) |
DB467357 | hippocampus | .h | 1 to 438 | 1 to 437 | | | | 437/440 (99 %) | 18 diff (96.0 %id) |
CX164682 | human embryonic stem cells differentiated toan early endodermal cell type | .h | 12 to 775 | 1 to 764 | | | | 764/764 (100 %) | 0 diff (100 %id) |
DB468915 | hippocampus | .h | 15 to 428 | 1 to 415 | | | | 415/415 (100 %) | 3 diff (99.3 %id) |
DB477927 | hippocampus | .h | 15 to 419 | 1 to 405 | | | | 405/410 (98 %) | 8 diff (98.1 %id) |
CB137934 | Liver | .h | 16 to 459 | 1 to 444 | | | | 444/444 (100 %) | 0 diff (100 %id) |
CB139357 | Liver | .h | 16 to 460 | 1 to 445 | | | | 445/445 (100 %) | 0 diff (100 %id) |
DB010848 | colon, tumor tissue | .h | 16 to 491 | 2 to 477 | | capped | | 476/476 (100 %) | 0 diff (100 %id) |
DN998918 | bone marrow | .h | 34 to 763 | 1 to 730 | | | | 730/730 (100 %) | 3 diff (99.6 %id) |
CX760723 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .h | 37 to 820 | 1 to 781 | | tiling clone, | Submitted on the opposite strand | 781/788 (99 %) | 11 diff (98.7 %id) |
BQ716872 | dorsal root ganglia | .h | 39 to 637 | 135 to 739 | | | | 605/1272 (47 %) | 16 diff (98.8 %id) |
BI113870 | muscle, rhabdomyosarcoma | .h | 47 to 778 | 1 to 728 | | | | 728/730 (99 %) | 22 diff (97.0 %id) |
CN288731 | embryonic stem cells, DMSO-treated H9 cellline | .h | 59 to 297 | 1 to 239 | | | | 239/239 (100 %) | 2 diff (99.2 %id) |
DB483171 | hippocampus | .h | 298 to 792 | 1 to 495 | | tiling clone, | | 495/495 (100 %) | 2 diff (99.6 %id) |
AA096445 | | .h | 348 to 579 | 1 to 230 | | | | 230/230 (100 %) | 16 diff (93.1 %id) |
DB294918 | | .h | 999 to 1584 | 586 to 1 | | tiling clone, | | 586/586 (100 %) | 0 diff (100 %id) |
BI222358 | cervical carcinoma cell line, cervix | .i | 1 to 793 | 1 to 794 | E186* | tiling clone, | | 794/794 (100 %) | 1 diff (99.9 %id) |
BU540219 | mixed (pool of 40 RNAs) | .i | 493 to 1068 | 1 to 576 | | tiling clone, | | 576/580 (99 %) | 1 diff (99.9 %id) |
DB451681 | testis | .j | 1 to 488 | 1 to 488 | | tiling clone, | | 488/488 (100 %) | 0 diff (100 %id) |
BM710852 | eye, fetal eyes | .j | 361 to 923 | 1 to 563 | | tiling clone, | | 563/563 (100 %) | 0 diff (100 %id) |
BQ213249 | large cell carcinoma, lung | .k | 1 to 593 | 4 to 604 | | | | 604/939 (64 %) | 16 diff (98.3 %id) |
CA406387 | adipose | .k | 1 to 244 | 2 to 245 | | | | 245/245 (100 %) | 0 diff (100 %id) |
BE279661 | choriocarcinoma, placenta | .k | 1 to 663 | 2 to 662 | | tiling clone, | | 662/674 (98 %) | 6 diff (99.2 %id) |
BG821985 | adenocarcinoma cell line, colon | .k | 4 to 750 | 1 to 748 | | tiling clone, | | 748/752 (99 %) | 9 diff (98.9 %id) |
BG769956 | melanotic melanoma, high MDR (cell line), skin | .k | 13 to 861 | 1 to 858 | E156D C157V N158* | tiling clone, | | 817/872 (93 %) | 32 diff (96.4 %id) |
BQ924767 | large cell carcinoma, lung | .k | 22 to 808 | 1 to 792 | | tiling clone, | | 790/956 (82 %) | 12 diff (98.8 %id) |
CN412684 | embryonic stem cells, DMSO-treated H9 cellline | .k | 28 to 368 | 1 to 341 | | | | 341/341 (100 %) | 0 diff (100 %id) |
DA101659 | cerebellum | .l | 1 to 529 | 5 to 533 | | capped | | 532/532 (100 %) | 3 diff (99.5 %id) |
DA659639 | | .l | 1 to 566 | 2 to 567 | | tiling clone, capped | | 566/566 (100 %) | 1 diff (99.9 %id) |
DA467597 | cord Blood | .l | 2 to 569 | 2 to 569 | | capped | | 568/568 (100 %) | 2 diff (99.7 %id) |
DA402649 | thalamus | .l | 3 to 560 | 2 to 560 | | capped | | 559/559 (100 %) | 1 diff (99.9 %id) |
DA704603 | | .l | 3 to 522 | 2 to 521 | | capped | | 520/520 (100 %) | 0 diff (100 %id) |
DA407760 | thalamus | .l | 5 to 558 | 2 to 555 | | capped | | 554/554 (100 %) | 0 diff (100 %id) |
CN362463 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .l | 8 to 725 | 1 to 718 | | | | 718/718 (100 %) | 1 diff (99.9 %id) |
DA854559 | placenta | .l | 8 to 571 | 2 to 566 | | capped | | 565/565 (100 %) | 2 diff (99.7 %id) |
DB232107 | trachea | .l | 8 to 511 | 2 to 506 | | capped | | 505/505 (100 %) | 1 diff (99.9 %id) |
BP286283 | lung | .l | 11 to 593 | 1 to 583 | | | | 583/583 (100 %) | 4 diff (99.4 %id) |
BP286288 | lung | .l | 11 to 591 | 1 to 582 | | | | 582/583 (99 %) | 14 diff (97.6 %id) |
BP288559 | lung | .l | 11 to 598 | 1 to 588 | | | | 588/588 (100 %) | 4 diff (99.4 %id) |
BX471704 | | .l | 13 to 489 | 1 to 471 | | | | 471/471 (100 %) | 7 diff (98.6 %id) |
DB193646 | ovary, tumor tissue | .l | 13 to 591 | 9 to 587 | | capped | | 579/579 (100 %) | 1 diff (99.9 %id) |
DA769357 | brain | .l | 18 to 594 | 2 to 578 | | capped | | 577/577 (100 %) | 3 diff (99.5 %id) |
DA034225 | | .l | 47 to 572 | 2 to 529 | | capped | | 528/528 (100 %) | 3 diff (99.5 %id) |
DA548805 | | .l | 47 to 603 | 2 to 559 | | capped | | 558/558 (100 %) | 2 diff (99.7 %id) |
DA949199 | Spleen | .l | 47 to 614 | 2 to 570 | | capped | | 569/569 (100 %) | 3 diff (99.5 %id) |
BP287669 | lung | .l | 48 to 626 | 1 to 580 | | | | 580/582 (99 %) | 8 diff (98.7 %id) |
DA477161 | | .l | 49 to 603 | 2 to 557 | | capped | | 556/556 (100 %) | 2 diff (99.7 %id) |
DA547464 | | .l | 49 to 610 | 2 to 565 | | capped | | 564/564 (100 %) | 3 diff (99.5 %id) |
DA667151 | | .l | 49 to 594 | 2 to 548 | | capped | | 547/547 (100 %) | 3 diff (99.5 %id) |
DA808770 | brain | .l | 49 to 610 | 2 to 564 | | capped | | 563/563 (100 %) | 2 diff (99.7 %id) |
DA859139 | placenta | .l | 49 to 611 | 2 to 565 | | capped | | 564/564 (100 %) | 2 diff (99.7 %id) |
DB016255 | esophageal, tumor tissue | .l | 49 to 615 | 2 to 569 | | capped | | 568/568 (100 %) | 2 diff (99.7 %id) |
DB088749 | testis | .l | 49 to 595 | 2 to 549 | | capped | | 548/548 (100 %) | 3 diff (99.5 %id) |
DB131703 | thymus | .l | 49 to 596 | 2 to 550 | | capped | | 549/549 (100 %) | 1 diff (99.9 %id) |
DB139830 | thymus | .l | 49 to 566 | 2 to 522 | | capped | | 521/521 (100 %) | 4 diff (99.3 %id) |
DB204049 | trachea | .l | 49 to 645 | 2 to 601 | | capped | | 600/600 (100 %) | 5 diff (99.2 %id) |
DB219155 | trachea | .l | 49 to 597 | 2 to 551 | | capped | | 550/550 (100 %) | 1 diff (99.9 %id) |
DB230464 | trachea | .l | 49 to 634 | 2 to 589 | | capped | | 588/588 (100 %) | 3 diff (99.5 %id) |
DB232122 | trachea | .l | 49 to 631 | 2 to 585 | | capped | | 584/584 (100 %) | 2 diff (99.7 %id) |
DB288671 | uterus | .l | 49 to 610 | 2 to 564 | | capped | | 563/563 (100 %) | 2 diff (99.7 %id) |
DB139242 | thymus | .l | 55 to 614 | 2 to 562 | | capped | | 561/561 (100 %) | 1 diff (99.9 %id) |
CN362433 | embryonic stem cells, cell lines H1, H7, andH9 | .l | 57 to 761 | 8 to 712 | | | | 705/712 (99 %) | 6 diff (99.2 %id) |
DB079873 | testis | .l | 57 to 635 | 2 to 581 | | capped | | 580/580 (100 %) | 2 diff (99.7 %id) |
CN362442 | embryonic stem cells, cell lines H1, H7, andH9 | .l | 60 to 307 | 1 to 249 | | | | 249/249 (100 %) | 3 diff (98.8 %id) |
BQ436344 | embryonal carcinoma, cell line, testis | .l | 63 to 911 | 1 to 861 | | tiling clone, | | 861/882 (97 %) | 19 diff (97.9 %id) |
BQ423441 | embryonal carcinoma, cell line, testis | .l | 132 to 920 | 1 to 793 | K126Q A130T P138A S149R R152T ... | tiling clone, | | 793/884 (89 %) | 19 diff (97.9 %id) |
CN362461 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .l | 177 to 853 | 1 to 677 | | tiling clone, | | 677/682 (99 %) | 1 diff (99.9 %id) |
AA341036 | Kidney | .m | -9 to 242 | 1 to 252 | | | | 252/252 (100 %) | 1 diff (99.7 %id) |
CN279139 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .m | 1 to 560 | 7 to 566 | | tiling clone, | | 566/566 (100 %) | 1 diff (99.9 %id) |
CR989586 | T-Lymphocytes | .m | 10 to 347 | 1 to 339 | | | | 339/350 (96 %) | 3 diff (99.2 %id) |
BY800153 | eye | .m | 376 to 915 | 1 to 539 | | | | 539/539 (100 %) | 1 diff (99.9 %id) |
AW503337 | lymph | .m | 388 to 684 | 1 to 297 | | | | 297/298 (99 %) | 6 diff (98.0 %id) |
CN279138 | embryonic stem cells, cell lines H1, H7, andH9 | .m | 450 to 750 | 1 to 303 | | | | 303/303 (100 %) | 3 diff (99.1 %id) |
AW270611 | endometrioid ovarian metastasis, ovary | .m | 498 to 946 | 1 to 452 | | tiling clone, | Submitted on the opposite strand | 452/452 (100 %) | 9 diff (98.1 %id) |
DB159557 | thymus | .m | 637 to 1226 | 2 to 591 | | tiling clone, capped | | 590/590 (100 %) | 0 diff (100 %id) |
BG714007 | brain, hypothalamus | .m | 743 to 1392 | 1 to 666 | T2* | tiling clone, | | 666/836 (79 %) | 41 diff (95.1 %id) |
DA993254 | synovial membrane tissue from rheumatioidarthritis | .m | 788 to 1325 | 2 to 540 | | tiling clone, capped | | 539/539 (100 %) | 1 diff (99.9 %id) |
NM_001143937.1 | | .n | 1 to 926 | 1 to 926 | exact | RefSeq, | | 926/926 (100 %) | 0 diff (100 %id) |
DC295281 | synovial membrane tissue from rheumatioidarthritis | .n | 16 to 570 | 1 to 556 | | tiling clone, | | 556/556 (100 %) | 1 diff (99.9 %id) |
AK303565 | thymus | .n | 64 to 1003 | 1 to 940 | | | | 940/940 (100 %) | 0 diff (100 %id) |
DC345236 | colon | .n | 64 to 622 | 1 to 560 | | | | 560/560 (100 %) | 4 diff (99.3 %id) |
DC410195 | thymus | .n | 64 to 642 | 1 to 579 | | | | 579/579 (100 %) | 0 diff (100 %id) |
DC380849 | placenta | .n | 66 to 610 | 1 to 546 | | | | 546/546 (100 %) | 1 diff (99.9 %id) |
BY996646 | | .n | 71 to 739 | 2 to 670 | | | | 669/670 (99 %) | 6 diff (99.2 %id) |
DC303866 | cerebellum | .n | 78 to 643 | 1 to 566 | | | | 566/566 (100 %) | 0 diff (100 %id) |
DC310266 | cerebellum | .n | 81 to 591 | 1 to 512 | | | | 512/513 (99 %) | 3 diff (99.5 %id) |
DC373339 | tongue | .n | 81 to 643 | 1 to 563 | | | | 563/563 (100 %) | 1 diff (99.9 %id) |
DC311963 | alzheimer cortex | .n | 84 to 636 | 1 to 554 | | | | 554/554 (100 %) | 1 diff (99.9 %id) |
DC311166 | alzheimer cortex | .n | 90 to 654 | 1 to 566 | | | | 566/566 (100 %) | 1 diff (99.9 %id) |
DC360506 | | .n | 90 to 660 | 1 to 572 | | | | 572/572 (100 %) | 1 diff (99.9 %id) |
CN412693 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .n | 93 to 726 | 1 to 633 | | | | 633/633 (100 %) | 1 diff (99.9 %id) |
DC393694 | colon, tumor tissue | .n | 93 to 657 | 1 to 565 | | | | 565/565 (100 %) | 1 diff (99.9 %id) |
DC295084 | synovial membrane tissue from rheumatioidarthritis | .n | 95 to 657 | 1 to 564 | | | | 564/564 (100 %) | 1 diff (99.9 %id) |
TI_57152558 | | .n | 96 to 707 | 34 to 642 | | | | 609/642 (94 %) | 8 diff (98.8 %id) |
TI_57240184 | | .n | 101 to 916 | 24 to 833 | | | | 810/833 (97 %) | 13 diff (98.5 %id) |
BI916696 | brain | .n | 104 to 916 | 1 to 807 | | | | 807/807 (100 %) | 9 diff (98.9 %id) |
BI764453 | pooled colon, kidney, stomach | .n | 105 to 707 | 1 to 600 | | | | 600/600 (100 %) | 4 diff (99.4 %id) |
TI_57162980 | | .n | 106 to 926 | 34 to 845 | | | | 812/845 (96 %) | 20 diff (97.7 %id) |
DC419374 | uterus, tumor tissue | .n | 107 to 671 | 1 to 565 | | | | 565/565 (100 %) | 1 diff (99.9 %id) |
DC326665 | caudate nucleus | .n | 108 to 667 | 1 to 560 | | | | 560/560 (100 %) | 0 diff (100 %id) |
BI838341 | pooled pancreas and spleen | .n | 108 to 926 | 1 to 811 | | | | 811/811 (100 %) | 17 diff (98.0 %id) |
DC407940 | thymus | .n | 108 to 654 | 1 to 547 | | | | 547/547 (100 %) | 0 diff (100 %id) |
DC422747 | uterus | .n | 108 to 654 | 1 to 547 | | | | 547/547 (100 %) | 0 diff (100 %id) |
BI838825 | pooled pancreas and spleen | .n | 110 to 1016 | 26 to 927 | | | | 902/928 (97 %) | 36 diff (96.2 %id) |
BI838788 | pooled pancreas and spleen | .n | 110 to 893 | 1 to 783 | | | | 783/783 (100 %) | 9 diff (98.9 %id) |
TI_57162382 | | .n | 110 to 893 | 1 to 783 | | | | 783/783 (100 %) | 9 diff (98.9 %id) |
TI_57162465 | | .n | 110 to 1016 | 26 to 927 | | | | 902/928 (97 %) | 36 diff (96.2 %id) |
TI_44185892 | | .n | 112 to 1040 | 19 to 944 | | | | 926/944 (98 %) | 67 diff (93.0 %id) |
BI522847 | brain | .n | 122 to 1040 | 1 to 916 | | | | 916/916 (100 %) | 62 diff (93.3 %id) |
CV570867 | cornea, eye | .n | 125 to 746 | 1 to 622 | | | | 622/622 (100 %) | 0 diff (100 %id) |
BI761723 | pooled colon, kidney, stomach | .n | 127 to 871 | 1 to 748 | | | | 748/748 (100 %) | 20 diff (97.4 %id) |
TI_57149262 | | .n | 127 to 871 | 36 to 783 | | | | 748/783 (95 %) | 25 diff (96.9 %id) |
BI762147 | pooled colon, kidney, stomach | .n | 149 to 843 | 38 to 725 | | | | 687/726 (94 %) | 20 diff (97.3 %id) |
BI771639 | pooled lung and spleen | .n | 149 to 809 | 24 to 682 | | | | 659/682 (96 %) | 4 diff (99.5 %id) |
BI838757 | pooled pancreas and spleen | .n | 149 to 792 | 57 to 713 | | | | 561/718 (78 %) | 40 diff (94.5 %id) |
TI_57151427 | | .n | 149 to 843 | 64 to 751 | | | | 687/752 (91 %) | 20 diff (97.4 %id) |
TI_57182307 | | .n | 149 to 809 | 90 to 748 | | | | 659/748 (88 %) | 4 diff (99.5 %id) |
TI_57162225 | | .n | 149 to 792 | 57 to 713 | | | | 561/718 (78 %) | 40 diff (94.5 %id) |
DR762267 | embryonic stem | .n | 232 to 1074 | 1 to 843 | | tiling clone, | | 843/843 (100 %) | 1 diff (99.9 %id) |
BG943320 | blood | .n | 579 to 1029 | 1 to 451 | | | | 451/451 (100 %) | 0 diff (100 %id) |
AA300895 | testis | .n | 747 to 998 | 1 to 252 | | | | 252/252 (100 %) | 7 diff (97.3 %id) |
BG122449 | adenocarcinoma, cell line, Liver | .o | 1 to 822 | 1 to 799 | W13G S14A Q16R G17Q R18D ... | tiling clone, | | 799/921 (86 %) | 25 diff (97.3 %id) |
BF754796 | colon | .o | 363 to 617 | 258 to 4 | | | Submitted on the opposite strand | 255/281 (90 %) | 1 diff (99.7 %id) |
BG956617 | colon | .o | 363 to 665 | 314 to 11 | | | | 304/349 (87 %) | 6 diff (98.3 %id) |
BE644842 | pooled | .o | 364 to 870 | 514 to 8 | | | | 507/514 (98 %) | 0 diff (100 %id) |
AI867988 | uterus | .o | 365 to 869 | 505 to 1 | | | | 505/505 (100 %) | 0 diff (100 %id) |
AI129389 | uterus | .o | 369 to 870 | 508 to 7 | | tiling clone, | | 502/508 (98 %) | 0 diff (100 %id) |
AI753850 | bone marrow stroma | .o | 390 to 869 | 498 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 480/480 (100 %) | 0 diff (100 %id) |
BF476360 | Prostate | .o | 396 to 869 | 474 to 1 | | | | 474/474 (100 %) | 0 diff (100 %id) |
BF196882 | pooled | .o | 396 to 870 | 481 to 7 | | | | 475/481 (98 %) | 0 diff (100 %id) |
TI_149272637 | | .o | 403 to 869 | 551 to 85 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 467/953 (49 %) | 0 diff (100 %id) |
DB552066 | hippocampus | .o | 405 to 868 | 1 to 464 | | | Submitted on the opposite strand | 464/465 (99 %) | 1 diff (99.8 %id) |
DB540942 | hippocampus | .o | 406 to 869 | 1 to 464 | | | Submitted on the opposite strand | 464/464 (100 %) | 0 diff (100 %id) |
DB550495 | hippocampus | .o | 406 to 868 | 1 to 463 | | | Submitted on the opposite strand | 463/463 (100 %) | 1 diff (99.8 %id) |
DB536375 | hippocampus | .o | 409 to 865 | 1 to 450 | | | Submitted on the opposite strand | 450/450 (100 %) | 27 diff (94.0 %id) |
BU675220 | lung, Primary Lung Epithelial Cells | .o | 411 to 869 | 477 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 459/459 (100 %) | 0 diff (100 %id) |
DB517168 | testis | .o | 422 to 869 | 1 to 448 | | | Submitted on the opposite strand | 448/448 (100 %) | 0 diff (100 %id) |
DB529269 | hippocampus | .o | 428 to 869 | 1 to 441 | | AAA | Submitted on the opposite strand | 441/441 (100 %) | 2 diff (99.6 %id) |
DB546320 | hippocampus | .o | 430 to 868 | 1 to 439 | | | Submitted on the opposite strand | 439/439 (100 %) | 1 diff (99.8 %id) |
AI358124 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .o | 431 to 869 | 439 to 1 | | | | 439/439 (100 %) | 0 diff (100 %id) |
DB546546 | hippocampus | .o | 440 to 865 | 1 to 426 | | | Submitted on the opposite strand | 426/426 (100 %) | 0 diff (100 %id) |
BG953793 | colon | .o | 449 to 666 | 220 to 7 | | | | 214/221 (96 %) | 1 diff (99.6 %id) |
N58882 | multiple sclerosis lesions | .o | 450 to 869 | 420 to 1 | | | | 420/420 (100 %) | 0 diff (100 %id) |
CD677040 | eye, Trabecular meshwork | .o | 451 to 869 | 1 to 419 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 419/419 (100 %) | 0 diff (100 %id) |
N23733 | melanocyte | .o | 453 to 869 | 417 to 1 | | | | 417/417 (100 %) | 0 diff (100 %id) |
DB561042 | hypothalamus | .o | 454 to 865 | 1 to 411 | | | Submitted on the opposite strand | 411/411 (100 %) | 2 diff (99.6 %id) |
BE328580 | 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney | .o | 454 to 870 | 417 to 1 | | | | 417/417 (100 %) | 0 diff (100 %id) |
DW407953 | Liver | .o | 477 to 867 | 453 to 62 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 392/392 (100 %) | 3 diff (99.3 %id) |
AW900069 | nervous_normal | .o | 496 to 853 | 355 to 1 | | | | 355/360 (98 %) | 3 diff (99.2 %id) |
TI_151714456 | | .o | 498 to 868 | 87 to 457 | | | Submitted on the opposite strand | 371/1360 (27 %) | 3 diff (99.8 %id) |
AA652402 | normal prostate, Prostate | .o | 506 to 869 | 364 to 1 | | | | 364/364 (100 %) | 0 diff (100 %id) |
EC510916 | Prostate | .o | 530 to 621 | 1 to 92 | | | | 92/92 (100 %) | 0 diff (100 %id) |
BM710988 | eye, fetal eyes | .o | 564 to 869 | 329 to 24 | | AAA | Submitted on the opposite strand | 306/306 (100 %) | 1 diff (99.7 %id) |
EC567793 | Prostate | .o | 583 to 680 | 1 to 98 | | | | 98/98 (100 %) | 0 diff (100 %id) |
AK293813 | cerebellum | .p | 1 to 1221 | 1 to 1221 | exact | tiling clone, | | 1221/1221 (100 %) | 1 diff (100.0 %id) |
DC307544 | cerebellum | .p | 1 to 557 | 1 to 557 | exact | | | 557/557 (100 %) | 0 diff (100 %id) |
BP432548 | | .p | 28 to 132 | 105 to 1 | | | | 105/105 (100 %) | 0 diff (100 %id) |
FN056586 | breast carcinoma | .p | 30 to 123 | 94 to 1 | | | Submitted on the opposite strand | 94/94 (100 %) | 0 diff (100 %id) |
BG942797 | blood | .p | 43 to 401 | 1 to 359 | | | | 359/359 (100 %) | 3 diff (99.2 %id) |
DC334996 | hippocampus | .q | 1 to 575 | 1 to 575 | exact | tiling clone, | | 575/575 (100 %) | 0 diff (100 %id) |
CA427064 | Bone, Subchondral Bone | .r | 1 to 739 | 753 to 19 | F15L V16Y L18* | tiling clone, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 735/735 (100 %) | 5 diff (99.4 %id) |
CR613717 | Placenta Cot 25-normalized | .s | 1 to 1394 | 1 to 1394 | exact | tiling clone, | | 1394/1394 (100 %) | 0 diff (100 %id) |
BX399819 | Placenta Cot 25-normalized | .t | 1 to 819 | 1 to 818 | M125X E128X | tiling clone, fully sequenced, | | 818/818 (100 %) | 2 diff (99.8 %id) |
BF696424 | brain, primitive neuroectoderm | .t | 14 to 1245 | 1 to 625 | | | | 531/894 (59 %) | 39 diff (95.7 %id) |
BP424409 | small intestine | .t | 1020 to 1552 | 1 to 535 | | tiling clone, | Submitted on the opposite strand | 535/535 (100 %) | 2 diff (99.7 %id) |
BG191310 | | .t | 1105 to 1782 | 697 to 20 | | | Submitted on the opposite strand | 678/897 (75 %) | 17 diff (98.2 %id) |
BU682728 | lung | .t | 1118 to 1798 | 699 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 681/681 (100 %) | 0 diff (100 %id) |
BQ774990 | Bone, Human Chondrosarcoma Cell Line | .t | 1118 to 1799 | 700 to 19 | | tiling clone, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 682/682 (100 %) | 0 diff (100 %id) |
CB850883 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .t | 1127 to 1799 | 691 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 673/682 (98 %) | 0 diff (100 %id) |
CB529074 | Aveolar Macrophage, lung | .t | 1128 to 1799 | 690 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 672/672 (100 %) | 0 diff (100 %id) |
EB361077 | eye, lens | .t | 1129 to 1672 | 545 to 1 | | | | 545/546 (99 %) | 3 diff (99.5 %id) |
BU631586 | cell lines, Chondrosarcoma | .t | 1135 to 1799 | 683 to 19 | | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 665/665 (100 %) | 0 diff (100 %id) |
BX399818 | Placenta Cot 25-normalized | .t | 1150 to 1750 | 603 to 3 | | fully sequenced, | | 812/814 (99 %) | 12 diff (98.6 %id) |
EB361110 | eye, lens | .t | 1150 to 1672 | 523 to 1 | | | | 523/523 (100 %) | 2 diff (99.7 %id) |
BM794532 | stomach | .t | 1150 to 1738 | 1 to 589 | | | | 589/589 (100 %) | 0 diff (100 %id) |
CA389476 | eye, RPE/choroid | .u | 1 to 501 | 501 to 1 | | tiling clone, | Submitted on the opposite strand | 501/501 (100 %) | 0 diff (100 %id) |
BY994684 | | .u | 114 to 806 | 17 to 709 | Y124L H125P N126H | tiling clone, | | 693/709 (97 %) | 8 diff (98.9 %id) |
DB285632 | uterus | .va | 1 to 547 | 2 to 548 | R82* | tiling clone, capped | | 547/547 (100 %) | 1 diff (99.9 %id) |
DA811390 | brain | .vb | 1 to 547 | 5 to 551 | exact | tiling clone, capped | | 550/550 (100 %) | 1 diff (99.9 %id) |
AA285052 | germinal center B cell | .vc | 1 to 437 | 1 to 437 | exact | tiling clone, | Submitted on the opposite strand | 437/437 (100 %) | 0 diff (100 %id) |
AI983533 | brain, three pooled meningiomas | .vd | 1 to 308 | 307 to 1 | L4F Q5K L8* | tiling clone, | | 305/307 (99 %) | 11 diff (96.5 %id) |
AW089845 | ovary, tumor, 5 pooled (see description) | .vd | 61 to 308 | 247 to 1 | | tiling clone, | | 247/247 (100 %) | 3 diff (98.8 %id) |
BX954306 | | .ve | 1 to 697 | 1 to 697 | exact | tiling clone, | | 697/697 (100 %) | 0 diff (100 %id) |
DC408490 | thymus | .vf | 1 to 551 | 1 to 551 | C48L R49Q A50S M51H S52V ... | tiling clone, | | 551/551 (100 %) | 4 diff (99.3 %id) |
AK128844 | thymus | .vg-u | 1 to 1208 | 2 to 1213 | | tiling clone, available from FLJ, | | 1213/1213 (100 %) | 3 diff (99.8 %id) |
DB143385 | thymus | .vg-u | 1 to 529 | 2 to 532 | | capped | | 531/531 (100 %) | 3 diff (99.5 %id) |
AK021446 | whole embryo, mainly head | .vg-u | 1061 to 2556 | 1 to 1496 | exact | tiling clone, available from FLJ, | | 1496/1496 (100 %) | 2 diff (99.9 %id) |
AA402414 | | .vg-u | 1852 to 2254 | 1 to 403 | | fully sequenced, | | 403/403 (100 %) | 0 diff (100 %id) |
AA453484 | | .vg-u | 1852 to 2237 | 1 to 386 | | fully sequenced, | | 386/386 (100 %) | 0 diff (100 %id) |
AA453485 | | .vg-u | 2207 to 2560 | 354 to 1 | | tiling clone, fully sequenced, | | 354/354 (100 %) | 0 diff (100 %id) |
AA412084 | | .vg-u | 2224 to 2556 | 333 to 1 | | fully sequenced, | | 333/333 (100 %) | 0 diff (100 %id) |
DA549688 | | .vi | 1 to 570 | 2 to 571 | | tiling clone, capped | | 570/570 (100 %) | 0 diff (100 %id) |
DA563892 | heart | .vi | 289 to 856 | 2 to 569 | | tiling clone, capped | | 568/568 (100 %) | 0 diff (100 %id) |
BY995449 | | .vi | 670 to 1417 | 3 to 750 | | tiling clone, | | 748/750 (99 %) | 6 diff (99.2 %id) |
BE739246 | hypernephroma, Kidney | .vi | 798 to 1504 | 1 to 693 | | | | 693/736 (94 %) | 20 diff (97.3 %id) |
CB120417 | Liver | .vi | 905 to 1549 | 1 to 645 | | | | 645/645 (100 %) | 0 diff (100 %id) |
AW361399 | colon | .vi | 1134 to 1571 | 439 to 2 | | | | 438/439 (99 %) | 6 diff (98.7 %id) |
DW413293 | Liver | .vi | 1179 to 1482 | 17 to 320 | | | | 304/320 (95 %) | 7 diff (97.9 %id) |
TI_149300970 | | .vi | 1198 to 2074 | 938 to 76 | G2A F6S | tiling clone, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 863/979 (88 %) | 25 diff (97.5 %id) |
TI_149308568 | | .vi | 1284 to 2074 | 869 to 84 | I22X N70T | AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 786/939 (83 %) | 6 diff (99.4 %id) |
DA569697 | whole embryo, mainly head | .vj | 1 to 854 | 2 to 856 | | tiling clone, capped | | 855/858 (99 %) | 13 diff (98.5 %id) |
AI074144 | Kidney | .vj | 889 to 1532 | 650 to 7 | exact | tiling clone, | | 644/650 (99 %) | 0 diff (100 %id) |
DB356387 | whole embryo, mainly head | .vj | 986 to 1531 | 543 to 1 | E5X T10P W11G S12V L13X ... | | | 543/543 (100 %) | 6 diff (98.9 %id) |
T67196 | liver and spleen | .vk-u | 1 to 384 | 1 to 385 | | tiling clone, fully sequenced, | | 385/385 (100 %) | 1 diff (99.8 %id) |
AI809507 | pooled | .vk-u | 172 to 699 | 529 to 2 | S3R | tiling clone, | | 528/529 (99 %) | 0 diff (100 %id) |
T67195 | liver and spleen | .vk-u | 354 to 695 | 348 to 1 | V10S E11R M12D S14I H15S ... | tiling clone, fully sequenced, | | 348/348 (100 %) | 6 diff (98.3 %id) |
TI_149308715 | | .vk-u | 519 to 1363 | 56 to 898 | | tiling clone, | Submitted on the opposite strand | 843/1049 (80 %) | 6 diff (99.5 %id) |
CB851460 | lung, Primary Lung Epithelial Cells | .vk-u | 519 to 1296 | 5 to 782 | | tiling clone, | Submitted on the opposite strand | 778/782 (99 %) | 6 diff (99.3 %id) |
DA058892 | cerebellum | .vl | 1 to 531 | 2 to 532 | | tiling clone, capped | | 531/531 (100 %) | 0 diff (100 %id) |
DB018326 | esophageal, tumor tissue | .vl | 16 to 587 | 2 to 574 | | capped | | 571/573 (99 %) | 1 diff (99.9 %id) |
DB148797 | thymus | .vl | 16 to 588 | 2 to 575 | | tiling clone, capped | | 572/574 (99 %) | 12 diff (98.0 %id) |
DB282375 | uterus | .vl | 16 to 558 | 2 to 545 | | capped | | 542/544 (99 %) | 1 diff (99.9 %id) |
BG461080 | | .vl | 412 to 1209 | 1 to 796 | F6L Q7G T8G R18K L45* | tiling clone, | | 796/801 (99 %) | 67 diff (91.7 %id) |
BX501393 | Liver | .vm-u | 1 to 696 | 1 to 695 | exact | tiling clone, | | 695/695 (100 %) | 5 diff (99.3 %id) |
BU852455 | testis | .vm-u | 626 to 1183 | 1 to 566 | | tiling clone, | | 566/835 (67 %) | 13 diff (98.5 %id) |
TI_1959498377 | | .vn | 1 to 270 | 525 to 256 | | tiling clone, | | 270/525 (51 %) | 0 diff (100 %id) |
DB456150.
matches multiple genes | testis | .vn | 128 to 603 | 1 to 476 | | tiling clone, | also hits gene pusmaby | 476/476 (100 %) | 1 diff (99.8 %id) |
AW341607 | pooled | .vn | 466 to 944 | 1 to 479 | | | Submitted on the opposite strand | 479/479 (100 %) | 4 diff (99.2 %id) |
AW341540 | pooled | .vn | 475 to 945 | 1 to 471 | | tiling clone, | Submitted on the opposite strand | 471/471 (100 %) | 4 diff (99.2 %id) |
CD237664 | Pituitary | .vn | 672 to 956 | 1 to 285 | | tiling clone, AAA | Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) | 285/285 (100 %) | 8 diff (97.2 %id) |
AA730410 | Ewing's sarcoma | .vn | 719 to 947 | 1 to 229 | | tiling clone, | | 229/229 (100 %) | 4 diff (98.3 %id) |
DB230762 | trachea | .vo | 1 to 606 | 2 to 607 | exact | tiling clone, capped | | 606/606 (100 %) | 1 diff (99.9 %id) |
DB217651 | trachea | .vo | 36 to 524 | 2 to 490 | exact | tiling clone, capped | | 489/489 (100 %) | 0 diff (100 %id) |
BX484531 | | .vp-u | 1 to 553 | 83 to 630 | exact | tiling clone, | | 548/630 (86 %) | 6 diff (99.1 %id) |
AI468365 | Prostate | .vp-u | 140 to 326 | 188 to 1 | | | | 188/188 (100 %) | 2 diff (99.0 %id) |
DB081783 | testis | .vq | 1 to 546 | 2 to 547 | exact | tiling clone, capped | | 546/546 (100 %) | 0 diff (100 %id) |
DA207941 | brain | .vr-u | 1 to 546 | 2 to 547 | T2L | tiling clone, capped | | 546/546 (100 %) | 4 diff (99.3 %id) |
BG008959 | placenta_normal | .vr-u | 87 to 542 | 456 to 1 | H8N | tiling clone, | | 456/456 (100 %) | 1 diff (99.8 %id) |
DB211596 | trachea | .vs | 1 to 534 | 5 to 538 | exact | tiling clone, capped | | 537/537 (100 %) | 1 diff (99.9 %id) |
BQ001143 | lung, Metastatic Chondrosarcoma | .vt | 1 to 520 | 538 to 19 | G6X | tiling clone, AAA | Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) | 520/520 (100 %) | 0 diff (100 %id) |
ES313750 | beard hair, skin | .vu | 1 to 314 | 1 to 314 | exact | tiling clone, | | 314/314 (100 %) | 0 diff (100 %id) |
DA355768 | subthalamic nucleus | Gene PSMA1andCOPB1, variant not shown | | | | capped | | | |
DA364042 | subthalamic nucleus | Gene PSMA1andCOPB1, variant not shown | | | | capped | | | |
DA427229 | colon | Gene PSMA1andCOPB1, variant not shown | | | | capped | | | |
DA558709 | | Gene PSMA1andCOPB1, variant not shown | | | | capped | | | |
BM472456 | melanotic melanoma, skin | Gene PSMA1andCOPB1, variant not shown | | | | | | | |
DA618840 | | Gene PSMA1andCOPB1, variant not shown | | | | capped | | | |
DA732172 | | Gene PSMA1andCOPB1, variant not shown | | | | capped | | | |
DB037362 | testis | Gene PSMA1andCOPB1, variant not shown | | | | capped | | | |
? | Gene Summary |
Gene on genome |
mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg-u, .vh, .vi, .vj, .vk-u, .vl, .vm-u, .vn, .vo, .vp-u, .vq, .vr-u, .vs, .vt, .vu |
Alternative mRNAs features, proteins, introns, exons, sequences |
Expression Tissue |
Function, regulation, related genes DCI |
To mine knowledge about the gene, please click the 'Gene Summary' or the 'Function, regulation, related genes ' tab at the top of the page. The 'Gene Summary' page includes all we learnt about the gene, functional annotations of neighboring genes, maps, links to other sites and the bibliography. The 'Function, regulation, related genes ' page includes Diseases (D), Pathways, GO annotations, conserved domains (C), interactions (I) reference into function, and pointers to all genes with the same functional annotation.
To compare alternative variants, their summarized annotations, predicted proteins, introns and exons, or to access any sequence, click the 'Alternative mRNAs features' tab. To see a specific mRNA variant diagram, sequence and annotation, click the variant name in the 'mRNA' tab. To examine expression data from all cDNAs clustered in this gene by AceView, click the 'Expression tissue'.
If you know more about this gene, or found errors, please share your knowledge. Thank you !